Sensata Technologies Holding (ST) 10-Q 27 Jul 21 2021 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2021	Jul. 15, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	001-34652
Entity Registrant Name	SENSATA TECHNOLOGIES HOLDING PLC
Entity Incorporation, State or Country Code	X0
Entity Tax Identification Number	98-1386780
Entity Address, Address Line One	529 Pleasant Street
Entity Address, City or Town	Attleboro
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02703
Entity Address, Country	US
City Area Code	+1 (508)
Local Phone Number	236 3800
Title of 12(b) Security	Ordinary Shares - nominal value €0.01 per share
Trading Symbol	ST
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		158,374,184
Entity Central Index Key	0001477294
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 1,861,769	$ 1,861,980
Accounts receivable, net of allowances of $20,223 and $19,033 as of June 30, 2021 and December 31, 2020, respectively	694,317	576,647
Inventories	503,641	451,005
Prepaid expenses and other current assets	117,401	90,340
Total current assets	3,177,128	2,979,972
Property, plant and equipment, net	801,342	803,825
Goodwill	3,308,939	3,111,349
Other intangible assets, net of accumulated amortization of $2,211,355 and $2,145,634 as of June 30, 2021 and December 31, 2020, respectively	892,521	691,549
Deferred income tax assets	79,625	84,785
Other assets	158,803	172,722
Total assets	8,418,358	7,844,202
Current liabilities:
Current portion of long-term debt, finance lease and other financing obligations	7,281	757,205
Accounts payable	473,932	393,907
Income taxes payable	25,663	19,215
Accrued expenses and other current liabilities	330,056	324,830
Total current liabilities	836,932	1,495,157
Deferred income tax liabilities	301,471	259,857
Pension and other post-retirement benefit obligations	44,146	48,002
Finance lease and other financing obligations, less current portion	27,220	27,931
Long-term debt, net	4,213,830	3,213,747
Other long-term liabilities	81,311	94,022
Total liabilities	5,504,910	5,138,716
Commitments and contingencies (Note 12)
Shareholders’ equity:
Ordinary shares, €0.01 nominal value per share, 177,069 shares authorized, and 174,005 and 173,266 shares issued as of June 30, 2021 and December 31, 2020, respectively	2,229	2,220
Treasury shares, at cost, 15,631 shares as of June 30, 2021 and December 31, 2020	(784,596)	(784,596)
Additional paid-in capital	1,789,863	1,759,668
Retained earnings	1,936,427	1,777,729
Accumulated other comprehensive loss	(30,475)	(49,535)
Total shareholders’ equity	2,913,448	2,705,486
Total liabilities and shareholders’ equity	$ 8,418,358	$ 7,844,202

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) $ in Thousands	Jun. 30, 2021USD ($)shares	Jun. 30, 2021€ / shares	Dec. 31, 2020USD ($)shares	Dec. 31, 2020€ / shares
Current assets:
Accounts receivable, allowances | $	$ 20,223		$ 19,033
Accumulated amortization | $	$ 2,211,355		$ 2,145,634
Shareholders’ equity:
Ordinary shares, nominal value per share (in euros per share) | € / shares		€ 0.01		€ 0.01
Common stock, shares authorized (in shares)	177,069,000		177,069,000
Common stock, shares, issued (in shares)	174,005,000		173,266,000
Treasury stock, shares (in shares)	15,631,000		15,631,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Net revenue	$ 992,660	$ 576,505	$ 1,935,188	$ 1,350,774
Operating costs and expenses:
Cost of revenue	658,285	412,443	1,293,634	978,849
Research and development	42,913	30,239	78,869	64,692
Selling, general and administrative	86,821	64,730	163,944	141,951
Amortization of intangible assets	34,857	32,743	66,921	65,835
Restructuring and other charges, net	5,029	38,218	9,611	42,716
Total operating costs and expenses	827,905	578,373	1,612,979	1,294,043
Operating income/(loss)	164,755	(1,868)	322,209	56,731
Interest expense, net	(45,213)	(40,808)	(89,256)	(80,211)
Other, net	1,012	1,576	(38,385)	(10,705)
Income/(loss) before taxes	120,554	(41,100)	194,568	(34,185)
Provision for/(benefit from) income taxes	7,638	1,441	27,919	(75)
Net income/(loss)	$ 112,916	$ (42,541)	$ 166,649	$ (34,110)
Basic net income/(loss) per share (in dollars per share)	$ 0.71	$ (0.27)	$ 1.05	$ (0.22)
Diluted net income/(loss) per share (in dollars per share)	$ 0.71	$ (0.27)	$ 1.05	$ (0.22)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income/(Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Statement of Comprehensive Income [Abstract]
Net income/(loss)	$ 112,916	$ (42,541)	$ 166,649	$ (34,110)
Other comprehensive income/(loss):
Cash flow hedges	1,398	(5,167)	15,676	(24,501)
Defined benefit and retiree healthcare plans	1,672	1,672	3,384	5,014
Other comprehensive income/(loss)	3,070	(3,495)	19,060	(19,487)
Comprehensive income/(loss)	$ 115,986	$ (46,036)	$ 185,709	$ (53,597)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities:
Net income/(loss)	$ 166,649	$ (34,110)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
Depreciation	62,833	65,288
Amortization of debt issuance costs	3,426	3,263
Share-based compensation	11,475	9,590
Loss on debt financing	30,066	0
Amortization of intangible assets	66,921	65,835
Deferred income taxes	(7,070)	1,500
Loss on litigation judgment	0	41,314
Unrealized loss on derivative instruments and other	12,700	8,035
Changes in operating assets and liabilities, net of the effects of acquisitions:
Accounts receivable, net	(97,906)	114,162
Inventories	(45,664)	17,871
Prepaid expenses and other current assets	(8,280)	14,790
Accounts payable and accrued expenses	68,764	(99,467)
Income taxes payable	6,448	(34,368)
Other	(2,431)	(3,431)
Net cash provided by operating activities	267,931	170,272
Cash flows from investing activities:
Acquisitions, net of cash received	(421,951)	0
Additions to property, plant and equipment and capitalized software	(63,572)	(56,697)
Investment in debt and equity securities	(6,444)	(5,817)
Other	2,862	2,019
Net cash used in investing activities	(489,105)	(60,495)
Cash flows from financing activities:
Proceeds from exercise of stock options and issuance of ordinary shares	17,957	1,146
Payment of employee restricted stock tax withholdings	(7,948)	(2,314)
Proceeds from borrowings on debt	1,001,875	400,000
Payments on debt	(757,889)	(4,604)
Payments to repurchase ordinary shares	0	(35,175)
Payments of debt financing costs	(33,032)	0
Net cash provided by financing activities	220,963	359,053
Net change in cash and cash equivalents	(211)	468,830
Cash and cash equivalents, beginning of period	1,861,980	774,119
Cash and cash equivalents, end of period	$ 1,861,769	$ 1,242,949

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Ordinary Shares	Treasury Shares	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2019		172,561	(14,733)
Beginning Balance at Dec. 31, 2019	$ 2,573,755	$ 2,212	$ (749,421)	$ 1,725,091	$ 1,616,357	$ (20,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Surrender of shares for tax withholding (in shares)			(83)
Surrender of shares for tax withholding	(2,314)		$ (2,314)
Stock options exercised (in shares)		55
Stock options exercised	1,146	$ 1		1,145
Vesting of restricted securities (in shares)		311
Vesting of restricted securities	0	$ 3			(3)
Repurchase of ordinary shares (in shares)			(898)
Repurchase of ordinary shares	(35,175)		$ (35,175)
Retirement of ordinary shares (in shares)		(83)	(83)
Retirement of ordinary shares	0	$ (1)	$ 2,314		(2,313)
Share-based compensation	9,590			9,590
Net income/(loss)	(34,110)				(34,110)
Other comprehensive income (loss)	(19,487)					(19,487)
Ending Balance (in shares) at Jun. 30, 2020		172,844	(15,631)
Ending Balance at Jun. 30, 2020	2,493,405	$ 2,215	$ (784,596)	1,735,826	1,579,931	(39,971)
Beginning Balance (in shares) at Mar. 31, 2020		172,596	(15,631)
Beginning Balance at Mar. 31, 2020	2,537,797	$ 2,212	$ (784,596)	1,731,884	1,624,773	(36,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Surrender of shares for tax withholding (in shares)			(83)
Surrender of shares for tax withholding	(2,299)		$ (2,299)
Stock options exercised (in shares)		21
Stock options exercised	437	$ 1		436
Vesting of restricted securities (in shares)		310
Vesting of restricted securities	0	$ 3			(3)
Retirement of ordinary shares (in shares)		(83)	(83)
Retirement of ordinary shares	0	$ (1)	$ 2,299		(2,298)
Share-based compensation	3,506			3,506
Net income/(loss)	(42,541)				(42,541)
Other comprehensive income (loss)	(3,495)					(3,495)
Ending Balance (in shares) at Jun. 30, 2020		172,844	(15,631)
Ending Balance at Jun. 30, 2020	2,493,405	$ 2,215	$ (784,596)	1,735,826	1,579,931	(39,971)
Beginning Balance (in shares) at Dec. 31, 2020		173,266	(15,631)
Beginning Balance at Dec. 31, 2020	2,705,486	$ 2,220	$ (784,596)	1,759,668	1,777,729	(49,535)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Surrender of shares for tax withholding (in shares)			(136)
Surrender of shares for tax withholding	(7,948)		$ (7,948)
Stock options exercised (in shares)		467
Stock options exercised	18,726	$ 6		18,720
Vesting of restricted securities (in shares)		408
Vesting of restricted securities	0	$ 5			(5)
Retirement of ordinary shares (in shares)		(136)	(136)
Retirement of ordinary shares	0	$ (2)	$ 7,948		(7,946)
Share-based compensation	11,475			11,475
Net income/(loss)	166,649				166,649
Other comprehensive income (loss)	19,060					19,060
Ending Balance (in shares) at Jun. 30, 2021		174,005	(15,631)
Ending Balance at Jun. 30, 2021	2,913,448	$ 2,229	$ (784,596)	1,789,863	1,936,427	(30,475)
Beginning Balance (in shares) at Mar. 31, 2021		173,533	(15,631)
Beginning Balance at Mar. 31, 2021	2,790,643	$ 2,223	$ (784,596)	1,775,320	1,831,241	(33,545)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Surrender of shares for tax withholding (in shares)			(132)
Surrender of shares for tax withholding	(7,727)		$ (7,727)
Stock options exercised (in shares)		208
Stock options exercised	8,170	$ 3		8,167
Vesting of restricted securities (in shares)		396
Vesting of restricted securities	0	$ 5			(5)
Retirement of ordinary shares (in shares)		(132)	(132)
Retirement of ordinary shares	0	$ (2)	$ 7,727		(7,725)
Share-based compensation	6,376			6,376
Net income/(loss)	112,916				112,916
Other comprehensive income (loss)	3,070					3,070
Ending Balance (in shares) at Jun. 30, 2021		174,005	(15,631)
Ending Balance at Jun. 30, 2021	$ 2,913,448	$ 2,229	$ (784,596)	$ 1,789,863	$ 1,936,427	$ (30,475)

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements reflect the financial position, results of operations, comprehensive income/(loss), cash flows, and changes in shareholders' equity of Sensata Technologies Holding plc, a public limited company incorporated under the laws of England and Wales, and its subsidiaries, collectively referred to as the "Company," "Sensata," "we," "our," or "us." The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q. Accordingly, these interim financial statements do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the interim period results. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020 (the "2020 Annual Report"). All U.S. dollar ("USD") and share amounts presented, except per share amounts, are stated in thousands, unless otherwise indicated. Certain reclassifications have been made to prior periods to conform to current period presentation.

New Accounting Standards

New Accounting Standards	6 Months Ended
	Jun. 30, 2021
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Standards	New Accounting StandardsThere are no recently issued accounting standards that have been adopted in the current period or will be adopted in future periods that have had or are expected to have a material impact on our consolidated financial position or results of operations.

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jun. 30, 2021
Revenue Recognition and Deferred Revenue [Abstract]
Revenue Recognition	Revenue Recognition The following tables presents net revenue disaggregated by segment and end market for the three and six months ended June 30, 2021 and 2020: For the three months ended June 30, 2021 For the three months ended June 30, 2020 Performance Sensing Sensing Solutions Total Performance Sensing Sensing Solutions Total Automotive $ 518,367 $ 12,052 $ 530,419 $ 286,499 $ 7,279 $ 293,778 HVOR (1) 223,485 — 223,485 98,708 — 98,708 Industrial — 105,474 105,474 — 79,264 79,264 Appliance and HVAC (2) — 63,187 63,187 — 43,689 43,689 Aerospace — 32,793 32,793 — 27,193 27,193 Other — 37,302 37,302 — 33,873 33,873 Total $ 741,852 $ 250,808 $ 992,660 $ 385,207 $ 191,298 $ 576,505 ________________________ (1) Heavy vehicle and off-road (2) Heating, ventilation and air conditioning For the six months ended June 30, 2021 For the six months ended June 30, 2020 Performance Sensing Sensing Solutions Total Performance Sensing Sensing Solutions Total Automotive $ 1,055,080 $ 23,552 $ 1,078,632 $ 724,202 $ 15,515 $ 739,717 HVOR 401,284 — 401,284 229,694 — 229,694 Industrial — 195,949 195,949 — 159,863 159,863 Appliance and HVAC — 123,103 123,103 — 89,085 89,085 Aerospace — 65,470 65,470 — 69,317 69,317 Other — 70,750 70,750 — 63,098 63,098 Total $ 1,456,364 $ 478,824 $ 1,935,188 $ 953,896 $ 396,878 $ 1,350,774

Share-Based Payment Plans

Share-Based Payment Plans	6 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Share-Based Payment Plans	Share-Based Payment Plans The following table presents the components of non-cash compensation expense related to our equity awards for the three and six months ended June 30, 2021 and 2020: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Stock options $ 305 $ 53 $ 765 $ 2,542 Restricted securities 6,071 3,453 10,710 7,048 Share-based compensation expense $ 6,376 $ 3,506 $ 11,475 $ 9,590 Equity Awards At our Annual General Meeting held on May 27, 2021, our shareholders approved the Sensata Technologies Holding plc 2021 Equity Incentive Plan (the "2021 Equity Plan"), which replaced the Sensata Technologies Holding plc First Amended and Restated 2010 Equity Incentive Plan (the "2010 Equity Plan"). The 2021 Equity Plan is substantially similar to the 2010 Equity Plan with some updates based on changes in law and current practices. The purpose of the 2021 Equity Plan is to promote the long-term growth, profitability, and interests of the Company and its shareholders by aiding us in attracting and retaining employees, officers, consultants, advisors, and non-employee directors capable of assuring our future success. All awards granted subsequent to this approval were made under the 2021 Equity Plan. We granted the following restricted stock units ("RSUs" and each, an "RSU") and performance-based restricted stock units ("PRSUs" and each, a "PRSU") under the 2021 Equity Plan and 2010 Equity Plan during the six months ended June 30, 2021: Awards Granted To: Type of Award Number of Units Granted (in thousands) Percentage of PRSUs Awarded that May Vest Weighted Average Grant Date Fair Value Directors RSU (1)(5) 27 N/A $ 58.63 Various executives and employees RSU (2)(4) 370 N/A $ 58.37 Various executives and employees PRSU (3)(4) 236 0.0% - 200.0% $ 58.20 ________________________ (1) These RSUs cliff vest one year from the grant date (May 2022). (2) RSUs vest ratably over three years, one-third per year beginning on the first anniversary of the grant date. These RSUs will fully vest on various dates between February 2024 and June 2024. (3) These PRSUs vest on various dates between April 2024 and May 2024. The number of units that ultimately vest is dependent on the achievement of certain performance criteria. (4) Primarily granted under the 2010 Equity Plan. (5) Primarily granted under the 2021 Equity Plan.

Restructuring and Other Charges

Restructuring and Other Charges, Net	6 Months Ended
	Jun. 30, 2021
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges, Net	Restructuring and Other Charges, Net On June 30, 2020, in response to the potential long-term impact of the global financial and health crisis caused by the coronavirus ("COVID-19") pandemic on our business, we committed to a plan to reorganize our business (the “Q2 2020 Global Restructure Program”), consisting of voluntary and involuntary reductions-in-force and certain site closures. The Q2 2020 Global Restructure Program was commenced in order to align our cost structure to the then anticipated future demand outlook. As of June 30, 2021, we have recorded cumulative costs of $30.1 million over the life of the plan, of which $27.4 million related to severance charges and $2.7 million related to facility and exit costs. We have completed a majority of the actions contemplated under the Q2 2020 Global Restructure Program. Reductions in force under the Q2 2020 Global Restructure Program have impacted approximately 560 positions as of June 30, 2021. When the remaining contemplated reduction-in-force actions are completed, which is expected in the third quarter of 2021, the total reductions in force are expected to be approximately 840 positions, reflecting total severance charges of between $27.0 million and $29.0 million. In addition, we expect total facility and exit costs incurred over the life of the Q2 2020 Global Restructure Program to be between $6.0 million and $8.0 million. We expect to settle these charges with cash on hand. We expect that when fully completed, restructuring actions taken under the Q2 2020 Global Restructure Program will have impacted our business segments and corporate functions as follows: Reductions-in-Force Site Closures (Dollars in millions) Positions Minimum Maximum Minimum Maximum Performance Sensing 170 $ 9.3 $ 10.0 $ 3.0 $ 4.0 Sensing Solutions 280 8.0 8.0 3.0 4.0 Corporate and other (1) 390 9.7 11.0 — — Total 840 $ 27.0 $ 29.0 $ 6.0 $ 8.0 ___________________________________ (1) The majority of these positions relate to engineering and manufacturing operations, which are allocated to corporate and other. However, these restructuring actions will benefit the results of Performance Sensing and Sensing Solutions as well. Charges recognized in the three and six months ended June 30, 2021 and 2020 resulting from the Q2 2020 Global Restructure Program are presented by impacted segment below. However, as noted in Note 17: Segment Reporting , restructuring and other charges, net are excluded from segment operating income. Approximately $1.0 million and $2.0 million of these charges in the three and six months ended June 30, 2021, respectively, relate to site closures in Sensing Solutions. Approximately $0.3 million of these charges in the three and six months ended June 30, 2021 relate to site closures in Performance Sensing. For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Performance Sensing $ 507 $ 7,609 $ 803 $ 7,609 Sensing Solutions 1,612 7,181 3,140 7,181 Corporate and other 1,711 9,330 1,711 9,330 Restructuring and other charges $ 3,830 $ 24,120 $ 5,654 $ 24,120 The following table presents the components of restructuring and other charges, net for the three and six months ended June 30, 2021 and 2020: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Q2 2020 Global Restructure Program charges $ 3,830 $ 24,120 $ 5,654 $ 24,120 Other restructuring charges Severance costs, net (1) 407 — 593 3,897 Facility and other exit costs 625 — 1,291 — Other (2) 167 14,098 2,073 14,699 Restructuring and other charges, net $ 5,029 $ 38,218 $ 9,611 $ 42,716 ___________________________________ (1) Severance costs, net (excluding those related to the Q2 2020 Global Restructure Program) for the six months ended June 30, 2020 were related to termination benefits arising from the shutdown and relocation of an operating site in Northern Ireland. (2) Other charges in the three and six months ended June 30, 2020 included a charge of $12.1 million resulting from a prejudgment interest-related award granted by the court on behalf of Wasica Finance GmbH ("Wasica") in intellectual property litigation in the second quarter of 2020. We settled this litigation with Wasica in the third quarter of 2020. The following table presents a rollforward of the severance portion of our restructuring obligations for the six months ended June 30, 2021. Q2 2020 Global Restructure Program Other Total Balance at December 31, 2020 $ 10,842 $ 4,037 $ 14,879 Charges, net of reversals 3,623 593 4,216 Payments (4,931) (2,888) (7,819) Foreign currency remeasurement (103) 32 (71) Balance at June 30, 2021 $ 9,431 $ 1,774 $ 11,205

Other, Net

Other, Net	6 Months Ended
	Jun. 30, 2021
Other Income and Expenses [Abstract]
Other, net	Other, Net The following table presents the components of other, net for the three and six months ended June 30, 2021 and 2020: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Currency remeasurement gain/(loss) on net monetary assets $ 1,988 $ (1,097) $ 511 $ 456 (Loss)/gain on foreign currency forward contracts (1,419) 417 (2,377) (3,364) Gain/(loss) on commodity forward contracts 1,186 5,427 33 (148) Loss on debt refinancing — — (30,066) — Net periodic benefit cost, excluding service cost (2,268) (2,516) (4,678) (6,897) Other 1,525 (655) (1,808) (752) Other, net $ 1,012 $ 1,576 $ (38,385) $ (10,705)

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The following table presents the provision for/(benefit from) income taxes for the three and six months ended June 30, 2021 and 2020: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Provision for/(benefit from) income taxes $ 7,638 $ 1,441 $ 27,919 $ (75) The increase in total tax for the three months ended June 30, 2021 compared to the three months ended June 30, 2020 was primarily due to the increase in pre-tax profits. The increase in total tax for the six months ended June 30, 2021 compared to the six months ended June 30, 2020 was predominantly due to the overall increase in income/(loss) before taxes as impacted by the mix of profits in the various jurisdictions in which we operate as well as the nonrecurrence of the benefit recorded in the first quarter of 2020 as a result of the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"). In response to the global financial and health crisis caused by COVID-19, the U.S. federal government enacted the CARES Act on March 27, 2020. Federal limitations on interest deductions were reduced in connection with this legislation, and we recorded a deferred tax benefit of $7.5 million in the three months ended March 31, 2020, as we were able to utilize additional interest expense that was previously subject to a valuation allowance. The provision for/(benefit from) income taxes consists of (1) current tax expense, which relates primarily to our profitable operations in tax jurisdictions with limited or no net operating loss carryforwards and withholding taxes related to management fees, royalties, and the repatriation of foreign earnings; and (2) deferred tax expense (or benefit), which represents adjustments in book-to-tax basis differences primarily related to (a) book versus tax basis in intangible assets, (b) changes in net operating loss carryforwards, (c) changes in tax rates, and (d) changes in our assessment of the realizability of our deferred tax assets.

Net Income_(Loss) per Share

Net Income/(Loss) per Share	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Net Income/(Loss) per Share	Net Income/(Loss) per Share Basic and diluted net income/(loss) per share are calculated by dividing net income/(loss) by the number of basic and diluted weighted-average ordinary shares outstanding during the period. For the three and six months ended June 30, 2021 and 2020 the weighted-average ordinary shares outstanding used to calculate basic and diluted net income/(loss) per share were as follows: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Basic weighted-average ordinary shares outstanding 158,208 157,186 157,986 157,392 Dilutive effect of stock options (1) 670 — 689 — Dilutive effect of unvested restricted securities (1) 466 — 612 — Diluted weighted-average ordinary shares outstanding 159,344 157,186 159,287 157,392 ___________________________________ (1) In the three and six months ended June 30, 2020, potential ordinary shares of approximately 66 thousand and 200 thousand, respectively, related to stock options and approximately 353 thousand and 403 thousand, respectively, related to unvested restricted securities were excluded from the calculation of diluted weighted-average ordinary shares outstanding as a result of the net loss incurred in those periods. Certain potential ordinary shares were excluded from our calculation of diluted weighted-average ordinary shares outstanding because either they would have had an anti–dilutive effect on net income/(loss) per share or they related to equity awards that were contingently issuable for which the contingency had not been satisfied. These potential ordinary shares were as follows: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Anti-dilutive shares excluded 8 2,959 7 2,172 Contingently issuable shares excluded 1,089 1,251 1,020 923

Inventories

Inventories	6 Months Ended
	Jun. 30, 2021
Inventory Disclosure [Abstract]
Inventories	Inventories The following table presents the components of inventories as of June 30, 2021 and December 31, 2020: June 30, 2021 December 31, 2020 Finished goods $ 161,378 $ 170,488 Work-in-process 98,194 87,006 Raw materials 244,069 193,511 Inventories $ 503,641 $ 451,005

Pension and Other Post-Retireme

Pension and Other Post-Retirement Benefits	6 Months Ended
	Jun. 30, 2021
Retirement Benefits [Abstract]
Pension and Other Post-Retirement Benefits	Pension and Other Post-Retirement Benefits The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the three months ended June 30, 2021 and 2020 were as follows: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total 2021 2020 2021 2020 2021 2020 2021 2020 Service cost $ — $ — $ 2 $ 3 $ 1,325 $ 939 $ 1,327 $ 942 Interest cost 120 206 21 36 401 396 542 638 Expected return on plan assets (226) (293) — — (179) (172) (405) (465) Amortization of net loss 401 300 — 9 462 359 863 668 Amortization of prior service (credit)/cost — — (159) (197) 13 3 (146) (194) Loss on settlement 1,414 310 — — — 1,559 1,414 1,869 Net periodic benefit cost/(credit) $ 1,709 $ 523 $ (136) $ (149) $ 2,022 $ 3,084 $ 3,595 $ 3,458 The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the six months ended June 30, 2021 and 2020 were as follows: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total 2021 2020 2021 2020 2021 2020 2021 2020 Service cost $ — $ — $ 4 $ 5 $ 2,303 $ 1,708 $ 2,307 $ 1,713 Interest cost 240 473 42 73 805 711 1,087 1,257 Expected return on plan assets (452) (726) — — (357) (346) (809) (1,072) Amortization of net loss 802 595 — 19 921 595 1,723 1,209 Amortization of prior service (credit)/cost — — (318) (393) 16 5 (302) (388) Loss on settlement 2,979 4,332 — — — 1,559 2,979 5,891 Net periodic benefit cost/(credit) $ 3,569 $ 4,674 $ (272) $ (296) $ 3,688 $ 4,232 $ 6,985 $ 8,610 Components of net periodic benefit cost/(credit) other than service cost are presented in other, net in the condensed consolidated statements of operations. Refer to Note 6: Other, Net .

Debt

Debt	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Debt	Debt Our long-term debt, finance lease, and other financing obligations as of June 30, 2021 and December 31, 2020 consisted of the following: Maturity Date June 30, 2021 December 31, 2020 Term Loan September 20, 2026 $ 453,780 $ 456,096 4.875% Senior Notes October 15, 2023 500,000 500,000 5.625% Senior Notes November 1, 2024 400,000 400,000 5.0% Senior Notes October 1, 2025 700,000 700,000 6.25% Senior Notes February 15, 2026 — 750,000 4.375% Senior Notes February 15, 2030 450,000 450,000 3.75% Senior Notes February 15, 2031 750,000 750,000 4.0% Senior Notes April 15, 2029 1,000,000 — Less: discount, net of premium (6,097) (9,605) Less: deferred financing costs (29,224) (28,114) Less: current portion (4,629) (754,630) Long-term debt, net $ 4,213,830 $ 3,213,747 Finance lease and other financing obligations $ 29,872 $ 30,506 Less: current portion (2,652) (2,575) Finance lease and other financing obligations, less current portion $ 27,220 $ 27,931 Revolving Credit Facility As of June 30, 2021, we had $416.1 million available under our $420.0 million revolving credit facility (the "Revolving Credit Facility"), net of $3.9 million of obligations in respect of outstanding letters of credit issued thereunder. Outstanding letters of credit are issued primarily for the benefit of certain operating activities. As of June 30, 2021, no amounts had been drawn against these outstanding letters of credit. 6.25% Senior Notes redemption On February 3, 2021, we announced that we intended to redeem in full the $750.0 million aggregate principal amount outstanding on our 6.25% senior notes due 2026 (the "6.25% Senior Notes"). On February 15, 2021, the “make-whole” premium with respect to the 6.25% Senior Notes expired. Accordingly, we reflected the 6.25% Senior Notes as a current liability on our consolidated balance sheet as of December 31, 2020. We redeemed the 6.25% Senior Notes on March 5, 2021 in accordance with the terms of the indenture under which the 6.25% Senior Notes were issued and the terms of the notice of redemption at a redemption price equal to 103.125% of the aggregate principal amount of the outstanding 6.25% Senior Notes, plus accrued and unpaid interest to (but not including) the redemption date. In addition to the $750.0 million aggregate principal amount outstanding, at redemption we paid the $23.4 million premium and $2.6 million accrued interest. 4.0% Senior Notes On March 29, 2021, our indirect, wholly-owned subsidiary, Sensata Technologies B.V. ("STBV"), completed the issuance and sale of $750.0 million aggregate principal amount of 4.0% senior notes due 2029 (the "4.0% Senior Notes"). The 4.0% Senior Notes were issued under an indenture dated as of March 29, 2021 among STBV, as issuer, The Bank of New York Mellon, as trustee (the "Trustee"), and our guarantor subsidiaries (the "Guarantors") named therein (the "4.0% Senior Notes Indenture"). The 4.0% Senior Notes Indenture contains covenants that limit the ability of STBV and its subsidiaries to, among other things: incur liens; engage in sale and leaseback transactions; with respect to any subsidiary of STBV, incur indebtedness without such subsidiary’s guaranteeing the 4.0% Senior Notes; or consolidate, merge with, or sell, assign, convey, transfer, lease, or otherwise dispose of all or substantially all of their properties or assets to, another person. These covenants are subject to important exceptions and qualifications set forth in the 4.0% Senior Notes Indenture. The 4.0% Senior Notes bear interest at 4.0% per year and mature on April 15, 2029. Interest is payable semi-annually on April 15 and October 15 of each year, commencing on October 15, 2021. The 4.0% Senior Notes are guaranteed by each of STBV's wholly-owned subsidiaries that is a borrower or guarantor under the senior secured credit facilities (the "Senior Secured Credit Facilities") of STBV's wholly-owned subsidiary Sensata Technologies, Inc. ("STI") and the issuer or a guarantor under our existing senior notes as follows: STBV's 4.875% Senior Notes due 2023, 5.625% Senior Notes due 2024, and 5.0% Senior Notes due 2025; and STI's 4.375% Senior Notes due 2030 and 3.75% Senior Notes due 2031. At any time, and from time to time, prior to April 15, 2024, STBV may redeem the 4.0% Senior Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the 4.0% Senior Notes being redeemed, plus a “make whole” premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. At any time on or after April 15, 2024, STBV may redeem the 4.0% Senior Notes, in whole or in part, at the following prices (expressed as a percentage of principal amount), plus accrued and unpaid interest, if any, up to but excluding the redemption date. Period beginning April 15, Price 2024 102.000 % 2025 101.000 % 2026 and thereafter 100.000 % In addition, at any time prior to April 15, 2024, STBV may redeem up to 40% of the principal amount of the outstanding 4.0% Senior Notes (including additional 4.0% Senior Notes, if any, that may be issued after March 29, 2021) with the net cash proceeds of certain equity offerings at a redemption price (expressed as a percentage of principal amount) of 104.00%, plus accrued and unpaid interest, if any, up to but excluding the redemption date, provided that at least 60% of the aggregate principal amount of the 4.0% Senior Notes (including additional 4.0% Senior Notes, if any) remains outstanding immediately after each such redemption. Upon the occurrence of certain changes in control, each holder of the 4.0% Senior Notes will have the right to require STBV to repurchase the 4.0% Senior Notes at 101% of their principal amount plus accrued and unpaid interest, if any, up to but excluding the date of repurchase. Upon changes in certain tax laws or treaties, or any change in the official application, administration, or interpretation thereof, STBV may, at its option, redeem the 4.0% Senior Notes, in whole but not in part, at a redemption price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, up to but excluding the redemption date, premium, if any, and all Additional Amounts (as defined in the 4.0% Senior Notes Indenture), if any, then due and which will become due on the date of redemption. On April 8, 2021, STBV completed the issuance and sale of an additional $250.0 million in aggregate principal amount of 4.0% Senior Notes (the “Additional Notes”). The Additional Notes were priced at 100.75% and were issued pursuant to the 4.0% Senior Notes Indenture, as supplemented by the First Supplemental Indenture, dated as of April 8, 2021, among STBV, the Guarantors, and the Trustee. The Additional Notes are consolidated and form a single class with the $750.0 million aggregate principal amount of 4.0% Senior Notes issued by STBV on March 29, 2021 (the “Initial Notes”). The Additional Notes have the same terms as the Initial Notes, other than with respect to the date of issuance and the issue price. We intend to use the net proceeds from the issuance and sale of the 4.0% Senior Notes and the Additional Notes for general corporate purposes, which may include working capital, capital expenditures, the acquisition of other companies, businesses, or assets, strategic investments, the refinancing or repayment of debt, and share repurchases. Accounting for Debt Financing Transactions We account for our debt financing transactions as disclosed in Note 2: Significant Accounting Policies of the audited consolidated financial statements and notes thereto included in our 2020 Annual Report. In connection with the redemption of the 6.25% Senior Notes, we recorded a loss of $30.1 million, which included $23.4 million in premiums paid, with the remaining loss representing write-off of debt discounts and deferred financing costs. In connection with the issuance of the 4.0% Senior Notes, we recognized $9.6 million of deferred financing costs, which are presented as a reduction of long-term debt on our condensed consolidated balance sheets and $1.7 million of issuance premiums, which are presented as an addition to long-term debt on our condensed consolidated balance sheets. Accrued Interest Accrued interest associated with our outstanding debt is included as a component of accrued expenses and other current liabilities in the condensed consolidated balance sheets. As of June 30, 2021 and December 31, 2020, accrued interest totaled $46.1 million and $53.6 million, respectively.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies We are regularly involved in a number of claims and litigation matters that arise in the ordinary course of business. Although it is not feasible to predict the outcome of these matters, based upon our experience and current information known to us, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our results of operations, financial position, and/or cash flows.

Shareholders' Equity

Shareholders' Equity	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Shareholders' Equity	Shareholders' Equity Treasury Shares From time to time, our Board of Directors has authorized various share repurchase programs, which may be modified or terminated by the Board at any time. We currently have an authorized $500.0 million share repurchase program under which approximately $302.3 million remained available as of June 30, 2021. On April 2, 2020, we announced a temporary suspension of this share repurchase program, which will remain on hold until we determine that market conditions warrant continuation of the program. Accumulated Other Comprehensive Loss The components of accumulated other comprehensive loss for the six months ended June 30, 2021 were as follows: Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Accumulated Other Comprehensive Loss Balance at December 31, 2020 $ (6,733) $ (42,802) $ (49,535) Other comprehensive income before reclassifications, net of tax 11,871 — 11,871 Reclassifications from accumulated other comprehensive loss, net of tax 3,805 3,384 7,189 Other comprehensive income 15,676 3,384 19,060 Balance at June 30, 2021 $ 8,943 $ (39,418) $ (30,475) The amounts reclassified from accumulated other comprehensive loss for the three and six months ended June 30, 2021 and 2020 were as follows: For the three months ended June 30, For the six months ended June 30, Affected Line in Condensed Consolidated Statements of Operations Component 2021 2020 2021 2020 Derivative instruments designated and qualifying as cash flow hedges: Foreign currency forward contracts $ 3,433 $ (6,392) $ 7,840 $ (13,015) Net revenue (1) Foreign currency forward contracts (2,024) 193 (2,767) (1,575) Cost of revenue (1) Total, before taxes 1,409 (6,199) 5,073 (14,590) Income/(loss) before taxes Income tax effect (352) 1,550 (1,268) 3,648 Provision for/(benefit from) income taxes Total, net of taxes $ 1,057 $ (4,649) $ 3,805 $ (10,942) Net income/(loss) Defined benefit and retiree healthcare plans $ 2,131 $ 2,343 $ 4,400 $ 6,712 Other, net (2) Income tax effect (459) (671) (1,016) (1,698) Provision for/(benefit from) income taxes Total, net of taxes $ 1,672 $ 1,672 $ 3,384 $ 5,014 Net income/(loss) __________________________ (1) Refer to Note 15: Derivative Instruments and Hedging Activities for additional information on amounts to be reclassified from accumulated other comprehensive loss in future periods. (2) Refer to Note 10: Pension and Other Post-Retirement Benefits for additional information on net periodic benefit cost/(credit).

Fair Value Measures

Fair Value Measures	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measures	Fair Value Measures Measured on a Recurring Basis The fair values of our assets and liabilities measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 are shown in the below table. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. June 30, 2021 December 31, 2020 Assets Foreign currency forward contracts $ 17,789 $ 16,163 Commodity forward contracts 5,479 8,902 Total $ 23,268 $ 25,065 Liabilities Foreign currency forward contracts $ 7,667 $ 24,660 Commodity forward contracts 2,016 310 Total $ 9,683 $ 24,970 Refer to Note 15: Derivative Instruments and Hedging Activities for additional information related to our forward contracts. Measured on a Nonrecurring Basis We evaluated our goodwill and other indefinite-lived intangible assets for impairment as of October 1, 2020 and determined that they were not impaired. During the six months ended June 30, 2021, no events or changes in circumstances occurred that would have triggered the need for an additional impairment review of these assets. Financial Instruments Not Recorded at Fair Value The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the condensed consolidated balance sheets as of June 30, 2021 and December 31, 2020. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. June 30, 2021 December 31, 2020 Carrying Value (1) Fair Value Carrying Value (1) Fair Value Liabilities Term Loan $ 453,780 $ 453,780 $ 456,096 $ 454,955 4.875% Senior Notes $ 500,000 $ 533,750 $ 500,000 $ 538,750 5.625% Senior Notes $ 400,000 $ 444,000 $ 400,000 $ 448,000 5.0% Senior Notes $ 700,000 $ 777,000 $ 700,000 $ 777,000 6.25% Senior Notes $ — $ — $ 750,000 $ 778,125 4.375% Senior Notes $ 450,000 $ 473,625 $ 450,000 $ 487,125 3.75% Senior Notes $ 750,000 $ 740,625 $ 750,000 $ 776,250 4.0% Senior Notes $ 1,000,000 $ 1,010,000 $ — $ — ___________________________________ (1) Excluding any related debt discounts, or premiums, and deferred financing costs. Cash and cash equivalents are carried at cost, which approximates fair value because of their short-term nature. In addition to the above, we hold certain equity investments that do not have readily determinable fair values for which we use the measurement alternative prescribed in Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 321, Investments - Equity Securities . Such investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. There were no impairments or changes resulting from observable transactions for any of these investments and no adjustments were made to their carrying values. Refer to the table below for the carrying values of equity investments using the measurement alternative, which are presented as a component of other assets in the condensed consolidated balance sheets. June 30, 2021 December 31, 2020 Quanergy $ 50,000 $ 50,000 Other 15,000 15,000 Total $ 65,000 $ 65,000 On June 22, 2021, Quanergy Systems, Inc. ("Quanergy") announced that it had entered into a definitive business combination agreement with CITIC Capital Acquisition Corp (NYSE: CCAC). Upon closing of the business combination, which is expected to be in the second half of 2021, subject to customary closing conditions, the combined company is expected to be listed on the New York Stock Exchange ("NYSE") under the ticker symbol QNGY. We have assessed our investment in Quanergy based on the proposed terms of the business combination agreement and concluded that there were no indicators of impairment as of June 30, 2021. Subsequent to closing, we will mark our investment to market each reporting period.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	6 Months Ended
	Jun. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	Derivative Instruments and Hedging Activities Hedges of Foreign Currency Risk For the three and six months ended June 30, 2021 and 2020, amounts excluded from the assessment of effectiveness of our foreign currency forward contracts that are designated as cash flow hedges were not material. As of June 30, 2021, we estimated that $9.2 million of net gains will be reclassified from accumulated other comprehensive loss to earnings during the twelve-month period ending June 30, 2022. As of June 30, 2021, we had the following outstanding foreign currency forward contracts: Notional Effective Date(s) Maturity Date(s) Index (Exchange Rates) Weighted-Average Strike Rate Hedge Designation (1) 14.0 EUR June 28, 2021 July 30, 2021 Euro ("EUR") to USD 1.19 USD Not designated 370.4 EUR Various from August 23, 2019 to June 22, 2021 Various from July 30, 2021 to June 30, 2023 EUR to USD 1.19 USD Cash flow hedge 696.0 CNY June 23, 2021 July 30, 2021 USD to Chinese Renminbi ("CNY") 6.51 CNY Not designated 520.8 CNY Various from November 5, 2020 to January 5, 2021 Various from July 30, 2021 to December 31, 2021 USD to CNY 6.66 CNY Cash flow hedge 450.0 JPY June 28, 2021 July 30, 2021 USD to Japanese Yen ("JPY") 110.82 JPY Not designated 20,066.7 KRW Various from August 23, 2019 to June 22, 2021 Various from July 30, 2021 to May 31, 2023 USD to Korean Won ("KRW") 1,143.12 KRW Cash flow hedge 26.0 MYR June 23, 2021 July 30, 2021 USD to Malaysian Ringgit ("MYR") 4.14 MYR Not designated 423.0 MXN June 28, 2021 July 30, 2021 USD to Mexican Peso ("MXN") 19.92 MXN Not designated 3,215.0 MXN Various from August 23, 2019 to June 22, 2021 Various from July 30, 2021 to June 30, 2023 USD to MXN 22.41 MXN Cash flow hedge 5.6 GBP June 28, 2021 July 30, 2021 British Pound Sterling ("GBP") to USD 1.39 USD Not Designated 51.3 GBP Various from August 23, 2019 to June 22, 2021 Various from July 30, 2021 to June 30, 2023 GBP to USD 1.33 USD Cash flow hedge _________________________ (1) Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve economic value, and they are not used for trading or speculative purposes. Hedges of Commodity Risk As of June 30, 2021, we had the following outstanding commodity forward contracts, none of which were designated for hedge accounting treatment in accordance with FASB ASC Topic 815, Derivatives and Hedging : Commodity Notional Remaining Contracted Periods Weighted-Average Strike Price Per Unit Silver 929,084 troy oz. July 2021 - June 2023 $24.51 Gold 8,943 troy oz. July 2021 - June 2023 $1,819.10 Nickel 202,117 pounds July 2021 - June 2023 $7.44 Aluminum 2,870,170 pounds July 2021 - June 2023 $0.97 Copper 2,842,272 pounds July 2021 - June 2023 $3.76 Platinum 9,540 troy oz. July 2021 - June 2023 $1,045.46 Palladium 1,256 troy oz. July 2021 - June 2023 $2,457.28 Financial Instrument Presentation The following table presents the fair values of our derivative financial instruments and their classification in the condensed consolidated balance sheets as of June 30, 2021 and December 31, 2020: Asset Derivatives Liability Derivatives Balance Sheet Location June 30, 2021 December 31, 2020 Balance Sheet Location June 30, 2021 December 31, 2020 Derivatives designated as hedging instruments Foreign currency forward contracts Prepaid expenses and other current assets $ 14,875 $ 11,281 Accrued expenses and other current liabilities $ 6,928 $ 18,834 Foreign currency forward contracts Other assets 2,860 4,728 Other long-term liabilities 284 5,182 Total $ 17,735 $ 16,009 $ 7,212 $ 24,016 Derivatives not designated as hedging instruments Commodity forward contracts Prepaid expenses and other current assets $ 5,041 $ 7,598 Accrued expenses and other current liabilities $ 1,216 $ 149 Commodity forward contracts Other assets 438 1,304 Other long-term liabilities 800 161 Foreign currency forward contracts Prepaid expenses and other current assets 54 154 Accrued expenses and other current liabilities 455 644 Total $ 5,533 $ 9,056 $ 2,471 $ 954 These fair value measurements were all categorized within Level 2 of the fair value hierarchy. The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income/(loss) for the three months ended June 30, 2021 and 2020: Derivatives designated as Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive Income/(Loss) Location of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss) Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss) 2021 2020 2021 2020 Foreign currency forward contracts $ (6,353) $ (5,954) Net revenue $ (3,433) $ 6,392 Foreign currency forward contracts $ 6,808 $ 5,267 Cost of revenue $ 2,024 $ (193) Derivatives not designated as Amount of Gain/(Loss) Recognized in Net Income/(Loss) Location of Gain/(Loss) Recognized in Net Income/(Loss) 2021 2020 Commodity forward contracts $ 1,186 $ 5,427 Other, net Foreign currency forward contracts $ (1,419) $ 417 Other, net The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income/(loss) for the six months ended June 30, 2021 and 2020: Derivatives designated as Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income/(Loss) Location of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss) Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss) 2021 2020 2021 2020 Foreign currency forward contracts $ 12,446 $ 6,590 Net revenue $ (7,840) $ 13,015 Foreign currency forward contracts $ 3,383 $ (24,363) Cost of revenue $ 2,767 $ 1,575 Derivatives not designated as Amount of Gain/(Loss) Recognized in Net Income/(Loss) Location of Gain/(Loss) Recognized in Net Income/(Loss) 2021 2020 Commodity forward contracts $ 33 $ (148) Other, net Foreign currency forward contracts $ (2,377) $ (3,364) Other, net Credit Risk Related Contingent Features We have agreements with our derivative counterparties that contain a provision whereby if we default on our indebtedness and repayment of the indebtedness has been accelerated by the lender, then we could also be declared in default on our derivative obligations.

Acquisitions

Acquisitions	6 Months Ended
	Jun. 30, 2021
Business Combination and Asset Acquisition [Abstract]
Acquisitions	Acquisitions On February 11, 2021, we entered into a securities purchase agreement (the "SPA") to acquire all of the outstanding equity interests of Xirgo Technologies, LLC ("Xirgo"), a leading provider of telematics and data insight, headquartered in Camarillo, California. The transaction contemplated by the SPA closed on April 1, 2021 for an aggregate cash purchase price of $408.7 million, subject to certain post-closing items. The product offerings and technology of Xirgo will augment our existing portfolio in advancing our Sensata Insights megatrend initiative. We expect to integrate Xirgo into our Performance Sensing reportable segment. The following table summarizes the preliminary allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed: Net working capital, excluding cash $ 11,536 Property, plant and equipment 1,427 Goodwill 184,260 Other intangible assets 249,612 Other assets 508 Deferred income tax liabilities (45,506) Other long-term liabilities (292) Fair value of net assets acquired, excluding cash and cash equivalents 401,545 Cash and cash equivalents 7,117 Fair value of net assets acquired $ 408,662 The allocation of purchase price of Xirgo is preliminary, and is based on management’s judgments after evaluating several factors, including preliminary valuation assessments of tangible and intangible assets. The final allocation of the purchase price to the assets acquired will be completed when the final valuations are completed. The preliminary goodwill recognized as a result of this acquisition was approximately $184.3 million, which represents future economic benefits expected to arise from synergies from combining operations and the extension of existing customer relationships. The amount of goodwill recorded that is expected to be deductible for tax purposes is not material. In connection with the allocation of purchase price to the assets acquired and liabilities assumed, we identified certain definite-lived intangible assets. The following table presents the acquired intangible assets, their estimated fair values, and weighted-average lives: Acquisition Date Fair Value Weighted-Average Lives (years) Acquired definite-lived intangible assets Customer relationships $ 198,540 15 Completed technologies 44,130 10 Tradenames 6,930 11 Other 12 1 Total definite-lived intangible assets acquired $ 249,612 14 The definite-lived intangible assets were valued using the income approach. We used the relief-from-royalty method to value completed technologies and tradenames, and we used the multi-period excess earnings method to value customer relationships. These valuation methods incorporate assumptions including expected discounted future cash flows resulting from either the future estimated after-tax royalty payments avoided as a result of owning the completed technologies or the future earnings related to existing customer relationships.

Segment Reporting

Segment Reporting	6 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting We operate in, and report financial information for, the following two reportable segments: Performance Sensing and Sensing Solutions. The Performance Sensing reportable segment consists of two operating segments, Automotive and HVOR, each of which meet the criteria for aggregation in FASB ASC Topic 280, Reportable Segments . The Sensing Solutions reportable segment is also an operating segment. Our operating segments are businesses that we manage as components of an enterprise, for which separate financial information is evaluated regularly by our chief operating decision maker in deciding how to allocate resources and assess performance. An operating segment’s performance is primarily evaluated based on segment operating income, which excludes amortization of intangible assets, restructuring and other charges, net, certain costs associated with our strategic megatrend initiatives, and certain corporate costs or credits not associated with the operations of the segment, including share-based compensation expense and a portion of depreciation expense associated with assets recorded in connection with acquisitions. Corporate and other costs excluded from an operating segment’s performance are separately stated below and also include costs that are related to functional areas, such as finance, information technology, legal, and human resources. We believe that segment operating income, as defined above, is an appropriate measure for evaluating the operating performance of our segments. However, this measure should be considered in addition to, and not as a substitute for, or superior to, operating income or other measures of financial performance prepared in accordance with U.S. GAAP. The accounting policies of each of our reporting segments are materially consistent with those in the summary of significant accounting policies as described in Note 2: Significant Accounting Policies of the audited consolidated financial statements and notes thereto included in our 2020 Annual Report. The following table presents net revenue and segment operating income for the reportable segments and other operating results not allocated to the reportable segments for the three and six months ended June 30, 2021 and 2020: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Net revenue: Performance Sensing $ 741,852 $ 385,207 $ 1,456,364 $ 953,896 Sensing Solutions 250,808 191,298 478,824 396,878 Total net revenue $ 992,660 $ 576,505 $ 1,935,188 $ 1,350,774 Segment operating income (as defined above): Performance Sensing $ 202,064 $ 60,756 $ 397,908 $ 195,802 Sensing Solutions 76,549 55,787 143,443 112,316 Total segment operating income 278,613 116,543 541,351 308,118 Corporate and other (73,972) (47,450) (142,610) (142,836) Amortization of intangible assets (34,857) (32,743) (66,921) (65,835) Restructuring and other charges, net (5,029) (38,218) (9,611) (42,716) Operating income/(loss) 164,755 (1,868) 322,209 56,731 Interest expense, net (45,213) (40,808) (89,256) (80,211) Other, net 1,012 1,576 (38,385) (10,705) Income/(loss) before taxes $ 120,554 $ (41,100) $ 194,568 $ (34,185)

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events

Basis of Presentation (Policies

Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q. Accordingly, these interim financial statements do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the interim period results. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020 (the "2020 Annual Report"). All U.S. dollar ("USD") and share amounts presented, except per share amounts, are stated in thousands, unless otherwise indicated.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jun. 30, 2021
Revenue Recognition and Deferred Revenue [Abstract]
Schedule of Disaggregation of Revenue	The following tables presents net revenue disaggregated by segment and end market for the three and six months ended June 30, 2021 and 2020: For the three months ended June 30, 2021 For the three months ended June 30, 2020 Performance Sensing Sensing Solutions Total Performance Sensing Sensing Solutions Total Automotive $ 518,367 $ 12,052 $ 530,419 $ 286,499 $ 7,279 $ 293,778 HVOR (1) 223,485 — 223,485 98,708 — 98,708 Industrial — 105,474 105,474 — 79,264 79,264 Appliance and HVAC (2) — 63,187 63,187 — 43,689 43,689 Aerospace — 32,793 32,793 — 27,193 27,193 Other — 37,302 37,302 — 33,873 33,873 Total $ 741,852 $ 250,808 $ 992,660 $ 385,207 $ 191,298 $ 576,505 ________________________ (1) Heavy vehicle and off-road (2) Heating, ventilation and air conditioning For the six months ended June 30, 2021 For the six months ended June 30, 2020 Performance Sensing Sensing Solutions Total Performance Sensing Sensing Solutions Total Automotive $ 1,055,080 $ 23,552 $ 1,078,632 $ 724,202 $ 15,515 $ 739,717 HVOR 401,284 — 401,284 229,694 — 229,694 Industrial — 195,949 195,949 — 159,863 159,863 Appliance and HVAC — 123,103 123,103 — 89,085 89,085 Aerospace — 65,470 65,470 — 69,317 69,317 Other — 70,750 70,750 — 63,098 63,098 Total $ 1,456,364 $ 478,824 $ 1,935,188 $ 953,896 $ 396,878 $ 1,350,774

Share-Based Payment Plans (Tabl

Share-Based Payment Plans (Tables)	6 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Non-cash Compensation Expense related to Equity Awards	The following table presents the components of non-cash compensation expense related to our equity awards for the three and six months ended June 30, 2021 and 2020: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Stock options $ 305 $ 53 $ 765 $ 2,542 Restricted securities 6,071 3,453 10,710 7,048 Share-based compensation expense $ 6,376 $ 3,506 $ 11,475 $ 9,590
Share-based Payment Arrangement, Restricted Stock Unit, Activity	We granted the following restricted stock units ("RSUs" and each, an "RSU") and performance-based restricted stock units ("PRSUs" and each, a "PRSU") under the 2021 Equity Plan and 2010 Equity Plan during the six months ended June 30, 2021: Awards Granted To: Type of Award Number of Units Granted (in thousands) Percentage of PRSUs Awarded that May Vest Weighted Average Grant Date Fair Value Directors RSU (1)(5) 27 N/A $ 58.63 Various executives and employees RSU (2)(4) 370 N/A $ 58.37 Various executives and employees PRSU (3)(4) 236 0.0% - 200.0% $ 58.20 ________________________ (1) These RSUs cliff vest one year from the grant date (May 2022). (2) RSUs vest ratably over three years, one-third per year beginning on the first anniversary of the grant date. These RSUs will fully vest on various dates between February 2024 and June 2024. (3) These PRSUs vest on various dates between April 2024 and May 2024. The number of units that ultimately vest is dependent on the achievement of certain performance criteria. (4) Primarily granted under the 2010 Equity Plan. (5) Primarily granted under the 2021 Equity Plan.

Restructuring and Other Charg_2

Restructuring and Other Charges, Net (Tables)	6 Months Ended
	Jun. 30, 2021
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Other Charges, Net	We expect that when fully completed, restructuring actions taken under the Q2 2020 Global Restructure Program will have impacted our business segments and corporate functions as follows: Reductions-in-Force Site Closures (Dollars in millions) Positions Minimum Maximum Minimum Maximum Performance Sensing 170 $ 9.3 $ 10.0 $ 3.0 $ 4.0 Sensing Solutions 280 8.0 8.0 3.0 4.0 Corporate and other (1) 390 9.7 11.0 — — Total 840 $ 27.0 $ 29.0 $ 6.0 $ 8.0 ___________________________________ (1) The majority of these positions relate to engineering and manufacturing operations, which are allocated to corporate and other. However, these restructuring actions will benefit the results of Performance Sensing and Sensing Solutions as well. Charges recognized in the three and six months ended June 30, 2021 and 2020 resulting from the Q2 2020 Global Restructure Program are presented by impacted segment below. However, as noted in Note 17: Segment Reporting , restructuring and other charges, net are excluded from segment operating income. Approximately $1.0 million and $2.0 million of these charges in the three and six months ended June 30, 2021, respectively, relate to site closures in Sensing Solutions. Approximately $0.3 million of these charges in the three and six months ended June 30, 2021 relate to site closures in Performance Sensing. For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Performance Sensing $ 507 $ 7,609 $ 803 $ 7,609 Sensing Solutions 1,612 7,181 3,140 7,181 Corporate and other 1,711 9,330 1,711 9,330 Restructuring and other charges $ 3,830 $ 24,120 $ 5,654 $ 24,120 The following table presents the components of restructuring and other charges, net for the three and six months ended June 30, 2021 and 2020: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Q2 2020 Global Restructure Program charges $ 3,830 $ 24,120 $ 5,654 $ 24,120 Other restructuring charges Severance costs, net (1) 407 — 593 3,897 Facility and other exit costs 625 — 1,291 — Other (2) 167 14,098 2,073 14,699 Restructuring and other charges, net $ 5,029 $ 38,218 $ 9,611 $ 42,716 ___________________________________ (1) Severance costs, net (excluding those related to the Q2 2020 Global Restructure Program) for the six months ended June 30, 2020 were related to termination benefits arising from the shutdown and relocation of an operating site in Northern Ireland.
Schedule of Changes to Restructuring Liability	The following table presents a rollforward of the severance portion of our restructuring obligations for the six months ended June 30, 2021. Q2 2020 Global Restructure Program Other Total Balance at December 31, 2020 $ 10,842 $ 4,037 $ 14,879 Charges, net of reversals 3,623 593 4,216 Payments (4,931) (2,888) (7,819) Foreign currency remeasurement (103) 32 (71) Balance at June 30, 2021 $ 9,431 $ 1,774 $ 11,205

Other, Net (Tables)

Other, Net (Tables)	6 Months Ended
	Jun. 30, 2021
Other Income and Expenses [Abstract]
Schedule of Other, Net	The following table presents the components of other, net for the three and six months ended June 30, 2021 and 2020: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Currency remeasurement gain/(loss) on net monetary assets $ 1,988 $ (1,097) $ 511 $ 456 (Loss)/gain on foreign currency forward contracts (1,419) 417 (2,377) (3,364) Gain/(loss) on commodity forward contracts 1,186 5,427 33 (148) Loss on debt refinancing — — (30,066) — Net periodic benefit cost, excluding service cost (2,268) (2,516) (4,678) (6,897) Other 1,525 (655) (1,808) (752) Other, net $ 1,012 $ 1,576 $ (38,385) $ (10,705)

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	The following table presents the provision for/(benefit from) income taxes for the three and six months ended June 30, 2021 and 2020: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Provision for/(benefit from) income taxes $ 7,638 $ 1,441 $ 27,919 $ (75)

Net Income_(Loss) per Share (Ta

Net Income/(Loss) per Share (Tables)	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Schedule of Weighted-average Ordinary Shares Outstanding	For the three and six months ended June 30, 2021 and 2020 the weighted-average ordinary shares outstanding used to calculate basic and diluted net income/(loss) per share were as follows: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Basic weighted-average ordinary shares outstanding 158,208 157,186 157,986 157,392 Dilutive effect of stock options (1) 670 — 689 — Dilutive effect of unvested restricted securities (1) 466 — 612 — Diluted weighted-average ordinary shares outstanding 159,344 157,186 159,287 157,392 ___________________________________ (1) In the three and six months ended June 30, 2020, potential ordinary shares of approximately 66 thousand and 200 thousand, respectively, related to stock options and approximately 353 thousand and 403 thousand, respectively, related to unvested restricted securities were excluded from the calculation of diluted weighted-average ordinary shares outstanding as a result of the net loss incurred in those periods.
Schedule of Antidilutive Securities	These potential ordinary shares were as follows: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Anti-dilutive shares excluded 8 2,959 7 2,172 Contingently issuable shares excluded 1,089 1,251 1,020 923

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Jun. 30, 2021
Inventory Disclosure [Abstract]
Schedule of Components of Inventories	The following table presents the components of inventories as of June 30, 2021 and December 31, 2020: June 30, 2021 December 31, 2020 Finished goods $ 161,378 $ 170,488 Work-in-process 98,194 87,006 Raw materials 244,069 193,511 Inventories $ 503,641 $ 451,005

Pension and Other Post-Retire_2

Pension and Other Post-Retirement Benefits (Tables)	6 Months Ended
	Jun. 30, 2021
Retirement Benefits [Abstract]
Schedule of Components of Net Periodic Benefit Cost	The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the three months ended June 30, 2021 and 2020 were as follows: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total 2021 2020 2021 2020 2021 2020 2021 2020 Service cost $ — $ — $ 2 $ 3 $ 1,325 $ 939 $ 1,327 $ 942 Interest cost 120 206 21 36 401 396 542 638 Expected return on plan assets (226) (293) — — (179) (172) (405) (465) Amortization of net loss 401 300 — 9 462 359 863 668 Amortization of prior service (credit)/cost — — (159) (197) 13 3 (146) (194) Loss on settlement 1,414 310 — — — 1,559 1,414 1,869 Net periodic benefit cost/(credit) $ 1,709 $ 523 $ (136) $ (149) $ 2,022 $ 3,084 $ 3,595 $ 3,458 The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the six months ended June 30, 2021 and 2020 were as follows: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total 2021 2020 2021 2020 2021 2020 2021 2020 Service cost $ — $ — $ 4 $ 5 $ 2,303 $ 1,708 $ 2,307 $ 1,713 Interest cost 240 473 42 73 805 711 1,087 1,257 Expected return on plan assets (452) (726) — — (357) (346) (809) (1,072) Amortization of net loss 802 595 — 19 921 595 1,723 1,209 Amortization of prior service (credit)/cost — — (318) (393) 16 5 (302) (388) Loss on settlement 2,979 4,332 — — — 1,559 2,979 5,891 Net periodic benefit cost/(credit) $ 3,569 $ 4,674 $ (272) $ (296) $ 3,688 $ 4,232 $ 6,985 $ 8,610

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Schedule of Long-term Debt and Capital Lease and Other Financing Obligations	Our long-term debt, finance lease, and other financing obligations as of June 30, 2021 and December 31, 2020 consisted of the following: Maturity Date June 30, 2021 December 31, 2020 Term Loan September 20, 2026 $ 453,780 $ 456,096 4.875% Senior Notes October 15, 2023 500,000 500,000 5.625% Senior Notes November 1, 2024 400,000 400,000 5.0% Senior Notes October 1, 2025 700,000 700,000 6.25% Senior Notes February 15, 2026 — 750,000 4.375% Senior Notes February 15, 2030 450,000 450,000 3.75% Senior Notes February 15, 2031 750,000 750,000 4.0% Senior Notes April 15, 2029 1,000,000 — Less: discount, net of premium (6,097) (9,605) Less: deferred financing costs (29,224) (28,114) Less: current portion (4,629) (754,630) Long-term debt, net $ 4,213,830 $ 3,213,747 Finance lease and other financing obligations $ 29,872 $ 30,506 Less: current portion (2,652) (2,575) Finance lease and other financing obligations, less current portion $ 27,220 $ 27,931
Schedule of Debt Instrument Redemption	Period beginning April 15, Price 2024 102.000 % 2025 101.000 % 2026 and thereafter 100.000 %

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Schedule of Roll forward of Components of Accumulated Other Comprehensive Loss	The components of accumulated other comprehensive loss for the six months ended June 30, 2021 were as follows: Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Accumulated Other Comprehensive Loss Balance at December 31, 2020 $ (6,733) $ (42,802) $ (49,535) Other comprehensive income before reclassifications, net of tax 11,871 — 11,871 Reclassifications from accumulated other comprehensive loss, net of tax 3,805 3,384 7,189 Other comprehensive income 15,676 3,384 19,060 Balance at June 30, 2021 $ 8,943 $ (39,418) $ (30,475)
Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss	The amounts reclassified from accumulated other comprehensive loss for the three and six months ended June 30, 2021 and 2020 were as follows: For the three months ended June 30, For the six months ended June 30, Affected Line in Condensed Consolidated Statements of Operations Component 2021 2020 2021 2020 Derivative instruments designated and qualifying as cash flow hedges: Foreign currency forward contracts $ 3,433 $ (6,392) $ 7,840 $ (13,015) Net revenue (1) Foreign currency forward contracts (2,024) 193 (2,767) (1,575) Cost of revenue (1) Total, before taxes 1,409 (6,199) 5,073 (14,590) Income/(loss) before taxes Income tax effect (352) 1,550 (1,268) 3,648 Provision for/(benefit from) income taxes Total, net of taxes $ 1,057 $ (4,649) $ 3,805 $ (10,942) Net income/(loss) Defined benefit and retiree healthcare plans $ 2,131 $ 2,343 $ 4,400 $ 6,712 Other, net (2) Income tax effect (459) (671) (1,016) (1,698) Provision for/(benefit from) income taxes Total, net of taxes $ 1,672 $ 1,672 $ 3,384 $ 5,014 Net income/(loss) __________________________ (1) Refer to Note 15: Derivative Instruments and Hedging Activities for additional information on amounts to be reclassified from accumulated other comprehensive loss in future periods. (2) Refer to Note 10: Pension and Other Post-Retirement Benefits for additional information on net periodic benefit cost/(credit).

Fair Value Measures (Tables)

Fair Value Measures (Tables)	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The fair values of our assets and liabilities measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 are shown in the below table. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. June 30, 2021 December 31, 2020 Assets Foreign currency forward contracts $ 17,789 $ 16,163 Commodity forward contracts 5,479 8,902 Total $ 23,268 $ 25,065 Liabilities Foreign currency forward contracts $ 7,667 $ 24,660 Commodity forward contracts 2,016 310 Total $ 9,683 $ 24,970
Schedule of Information about Carrying Values and Fair Values of Financial Instruments not Recorded at Fair Value	The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the condensed consolidated balance sheets as of June 30, 2021 and December 31, 2020. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. June 30, 2021 December 31, 2020 Carrying Value (1) Fair Value Carrying Value (1) Fair Value Liabilities Term Loan $ 453,780 $ 453,780 $ 456,096 $ 454,955 4.875% Senior Notes $ 500,000 $ 533,750 $ 500,000 $ 538,750 5.625% Senior Notes $ 400,000 $ 444,000 $ 400,000 $ 448,000 5.0% Senior Notes $ 700,000 $ 777,000 $ 700,000 $ 777,000 6.25% Senior Notes $ — $ — $ 750,000 $ 778,125 4.375% Senior Notes $ 450,000 $ 473,625 $ 450,000 $ 487,125 3.75% Senior Notes $ 750,000 $ 740,625 $ 750,000 $ 776,250 4.0% Senior Notes $ 1,000,000 $ 1,010,000 $ — $ — ___________________________________ (1) Excluding any related debt discounts, or premiums, and deferred financing costs.
Schedule of Equity Securities without Readily Determinable Fair Value	Refer to the table below for the carrying values of equity investments using the measurement alternative, which are presented as a component of other assets in the condensed consolidated balance sheets. June 30, 2021 December 31, 2020 Quanergy $ 50,000 $ 50,000 Other 15,000 15,000 Total $ 65,000 $ 65,000

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	6 Months Ended
	Jun. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Outstanding Derivative Instruments	As of June 30, 2021, we had the following outstanding foreign currency forward contracts: Notional Effective Date(s) Maturity Date(s) Index (Exchange Rates) Weighted-Average Strike Rate Hedge Designation (1) 14.0 EUR June 28, 2021 July 30, 2021 Euro ("EUR") to USD 1.19 USD Not designated 370.4 EUR Various from August 23, 2019 to June 22, 2021 Various from July 30, 2021 to June 30, 2023 EUR to USD 1.19 USD Cash flow hedge 696.0 CNY June 23, 2021 July 30, 2021 USD to Chinese Renminbi ("CNY") 6.51 CNY Not designated 520.8 CNY Various from November 5, 2020 to January 5, 2021 Various from July 30, 2021 to December 31, 2021 USD to CNY 6.66 CNY Cash flow hedge 450.0 JPY June 28, 2021 July 30, 2021 USD to Japanese Yen ("JPY") 110.82 JPY Not designated 20,066.7 KRW Various from August 23, 2019 to June 22, 2021 Various from July 30, 2021 to May 31, 2023 USD to Korean Won ("KRW") 1,143.12 KRW Cash flow hedge 26.0 MYR June 23, 2021 July 30, 2021 USD to Malaysian Ringgit ("MYR") 4.14 MYR Not designated 423.0 MXN June 28, 2021 July 30, 2021 USD to Mexican Peso ("MXN") 19.92 MXN Not designated 3,215.0 MXN Various from August 23, 2019 to June 22, 2021 Various from July 30, 2021 to June 30, 2023 USD to MXN 22.41 MXN Cash flow hedge 5.6 GBP June 28, 2021 July 30, 2021 British Pound Sterling ("GBP") to USD 1.39 USD Not Designated 51.3 GBP Various from August 23, 2019 to June 22, 2021 Various from July 30, 2021 to June 30, 2023 GBP to USD 1.33 USD Cash flow hedge _________________________ (1) Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve economic value, and they are not used for trading or speculative purposes. As of June 30, 2021, we had the following outstanding commodity forward contracts, none of which were designated for hedge accounting treatment in accordance with FASB ASC Topic 815, Derivatives and Hedging : Commodity Notional Remaining Contracted Periods Weighted-Average Strike Price Per Unit Silver 929,084 troy oz. July 2021 - June 2023 $24.51 Gold 8,943 troy oz. July 2021 - June 2023 $1,819.10 Nickel 202,117 pounds July 2021 - June 2023 $7.44 Aluminum 2,870,170 pounds July 2021 - June 2023 $0.97 Copper 2,842,272 pounds July 2021 - June 2023 $3.76 Platinum 9,540 troy oz. July 2021 - June 2023 $1,045.46 Palladium 1,256 troy oz. July 2021 - June 2023 $2,457.28
Schedule of Fair Values of Derivative Financial Instruments and their Classification in Balance Sheets	The following table presents the fair values of our derivative financial instruments and their classification in the condensed consolidated balance sheets as of June 30, 2021 and December 31, 2020: Asset Derivatives Liability Derivatives Balance Sheet Location June 30, 2021 December 31, 2020 Balance Sheet Location June 30, 2021 December 31, 2020 Derivatives designated as hedging instruments Foreign currency forward contracts Prepaid expenses and other current assets $ 14,875 $ 11,281 Accrued expenses and other current liabilities $ 6,928 $ 18,834 Foreign currency forward contracts Other assets 2,860 4,728 Other long-term liabilities 284 5,182 Total $ 17,735 $ 16,009 $ 7,212 $ 24,016 Derivatives not designated as hedging instruments Commodity forward contracts Prepaid expenses and other current assets $ 5,041 $ 7,598 Accrued expenses and other current liabilities $ 1,216 $ 149 Commodity forward contracts Other assets 438 1,304 Other long-term liabilities 800 161 Foreign currency forward contracts Prepaid expenses and other current assets 54 154 Accrued expenses and other current liabilities 455 644 Total $ 5,533 $ 9,056 $ 2,471 $ 954
Schedule of Effect of Derivative Financial Instruments on Statements of Operations	The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income/(loss) for the three months ended June 30, 2021 and 2020: Derivatives designated as Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive Income/(Loss) Location of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss) Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss) 2021 2020 2021 2020 Foreign currency forward contracts $ (6,353) $ (5,954) Net revenue $ (3,433) $ 6,392 Foreign currency forward contracts $ 6,808 $ 5,267 Cost of revenue $ 2,024 $ (193) Derivatives not designated as Amount of Gain/(Loss) Recognized in Net Income/(Loss) Location of Gain/(Loss) Recognized in Net Income/(Loss) 2021 2020 Commodity forward contracts $ 1,186 $ 5,427 Other, net Foreign currency forward contracts $ (1,419) $ 417 Other, net The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income/(loss) for the six months ended June 30, 2021 and 2020: Derivatives designated as Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income/(Loss) Location of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss) Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss) 2021 2020 2021 2020 Foreign currency forward contracts $ 12,446 $ 6,590 Net revenue $ (7,840) $ 13,015 Foreign currency forward contracts $ 3,383 $ (24,363) Cost of revenue $ 2,767 $ 1,575 Derivatives not designated as Amount of Gain/(Loss) Recognized in Net Income/(Loss) Location of Gain/(Loss) Recognized in Net Income/(Loss) 2021 2020 Commodity forward contracts $ 33 $ (148) Other, net Foreign currency forward contracts $ (2,377) $ (3,364) Other, net

Acquisitions (Tables)

Acquisitions (Tables)	6 Months Ended
	Jun. 30, 2021
Business Combination and Asset Acquisition [Abstract]
Schedule of Fair Values of Assets Acquired and Liabilities Assumed	The following table summarizes the preliminary allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed: Net working capital, excluding cash $ 11,536 Property, plant and equipment 1,427 Goodwill 184,260 Other intangible assets 249,612 Other assets 508 Deferred income tax liabilities (45,506) Other long-term liabilities (292) Fair value of net assets acquired, excluding cash and cash equivalents 401,545 Cash and cash equivalents 7,117 Fair value of net assets acquired $ 408,662
Schedule of Finite-Lived Intangible Assets Acquired and Weighted Average Useful Lives	The following table presents the acquired intangible assets, their estimated fair values, and weighted-average lives: Acquisition Date Fair Value Weighted-Average Lives (years) Acquired definite-lived intangible assets Customer relationships $ 198,540 15 Completed technologies 44,130 10 Tradenames 6,930 11 Other 12 1 Total definite-lived intangible assets acquired $ 249,612 14

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Schedule of Segment Reporting Information by Segment	The following table presents net revenue and segment operating income for the reportable segments and other operating results not allocated to the reportable segments for the three and six months ended June 30, 2021 and 2020: For the three months ended For the six months ended June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020 Net revenue: Performance Sensing $ 741,852 $ 385,207 $ 1,456,364 $ 953,896 Sensing Solutions 250,808 191,298 478,824 396,878 Total net revenue $ 992,660 $ 576,505 $ 1,935,188 $ 1,350,774 Segment operating income (as defined above): Performance Sensing $ 202,064 $ 60,756 $ 397,908 $ 195,802 Sensing Solutions 76,549 55,787 143,443 112,316 Total segment operating income 278,613 116,543 541,351 308,118 Corporate and other (73,972) (47,450) (142,610) (142,836) Amortization of intangible assets (34,857) (32,743) (66,921) (65,835) Restructuring and other charges, net (5,029) (38,218) (9,611) (42,716) Operating income/(loss) 164,755 (1,868) 322,209 56,731 Interest expense, net (45,213) (40,808) (89,256) (80,211) Other, net 1,012 1,576 (38,385) (10,705) Income/(loss) before taxes $ 120,554 $ (41,100) $ 194,568 $ (34,185)

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Net revenue	$ 992,660	$ 576,505	$ 1,935,188	$ 1,350,774
Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	741,852	385,207	1,456,364	953,896
Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	250,808	191,298	478,824	396,878
Automotive
Disaggregation of Revenue [Line Items]
Net revenue	530,419	293,778	1,078,632	739,717
Automotive | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	518,367	286,499	1,055,080	724,202
Automotive | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	12,052	7,279	23,552	15,515
HVOR
Disaggregation of Revenue [Line Items]
Net revenue	223,485	98,708	401,284	229,694
HVOR | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	223,485	98,708	401,284	229,694
HVOR | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Industrial
Disaggregation of Revenue [Line Items]
Net revenue	105,474	79,264	195,949	159,863
Industrial | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Industrial | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	105,474	79,264	195,949	159,863
Appliance and HVAC
Disaggregation of Revenue [Line Items]
Net revenue	63,187	43,689	123,103	89,085
Appliance and HVAC | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Appliance and HVAC | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	63,187	43,689	123,103	89,085
Aerospace
Disaggregation of Revenue [Line Items]
Net revenue	32,793	27,193	65,470	69,317
Aerospace | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Aerospace | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	32,793	27,193	65,470	69,317
Other
Disaggregation of Revenue [Line Items]
Net revenue	37,302	33,873	70,750	63,098
Other | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Other | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	$ 37,302	$ 33,873	$ 70,750	$ 63,098

Share-Based Payment Plans - Sha

Share-Based Payment Plans - Share-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 6,376	$ 3,506	$ 11,475	$ 9,590
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	305	53	765	2,542
Restricted securities
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 6,071	$ 3,453	$ 10,710	$ 7,048

Share-Based Payment Plans - Equ

Share-Based Payment Plans - Equity Awards (Details) shares in Thousands	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Directors | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of units granted (in shares) | shares	27
Weighted-average grant date fair value (in dollars per share) | $ / shares	$ 58.63
Award vesting period	1 year
Various executives and employees | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of units granted (in shares) | shares	370
Weighted-average grant date fair value (in dollars per share) | $ / shares	$ 58.37
Award vesting period	3 years
Award vesting percentage	33.33%
Various executives and employees | PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of units granted (in shares) | shares	236
Weighted-average grant date fair value (in dollars per share) | $ / shares	$ 58.20
Various executives and employees | PRSU | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of PRSUs Awarded that May Vest	200.00%
Various executives and employees | PRSU | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of PRSUs Awarded that May Vest	0.00%

Restructuring and Other Charg_3

Restructuring and Other Charges, Net - Narrative (Details) $ in Thousands	3 Months Ended		6 Months Ended		9 Months Ended
	Jun. 30, 2021USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2021USD ($)position	Jun. 30, 2020USD ($)	Sep. 30, 2021position
Q2 2020 Global Restructure Program
Restructuring Cost and Reserve [Line Items]
Restructuring cost incurred to date	$ 30,100		$ 30,100
Number of positions eliminated in restructuring | position			560
Restructuring and other charges	3,830	$ 24,120	$ 5,654	$ 24,120
Q2 2020 Global Restructure Program | Forecast
Restructuring Cost and Reserve [Line Items]
Expected number of positions eliminated | position					840
Q2 2020 Global Restructure Program | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Expected number of positions eliminated | position			280
Restructuring and other charges	1,612	7,181	$ 3,140	7,181
Q2 2020 Global Restructure Program | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Expected number of positions eliminated | position			170
Restructuring and other charges	507	$ 7,609	$ 803	$ 7,609
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges			4,216
Employee Severance | Q2 2020 Global Restructure Program
Restructuring Cost and Reserve [Line Items]
Restructuring cost incurred to date	27,400		27,400
Restructuring and other charges			3,623
Site Closures | Q2 2020 Global Restructure Program
Restructuring Cost and Reserve [Line Items]
Restructuring cost incurred to date	2,700		2,700
Restructuring and other charges	300
Site Closures | Q2 2020 Global Restructure Program | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	1,000		2,000
Site Closures | Q2 2020 Global Restructure Program | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges			300
Minimum | Employee Severance | Q2 2020 Global Restructure Program
Restructuring Cost and Reserve [Line Items]
Expected cost	27,000		27,000
Minimum | Employee Severance | Q2 2020 Global Restructure Program | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Expected cost	8,000		8,000
Minimum | Employee Severance | Q2 2020 Global Restructure Program | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Expected cost	9,300		9,300
Minimum | Site Closures | Q2 2020 Global Restructure Program
Restructuring Cost and Reserve [Line Items]
Expected cost	6,000		6,000
Minimum | Site Closures | Q2 2020 Global Restructure Program | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Expected cost	3,000		3,000
Minimum | Site Closures | Q2 2020 Global Restructure Program | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Expected cost	3,000		3,000
Maximum | Employee Severance | Q2 2020 Global Restructure Program
Restructuring Cost and Reserve [Line Items]
Expected cost	29,000		29,000
Maximum | Employee Severance | Q2 2020 Global Restructure Program | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Expected cost	8,000		8,000
Maximum | Employee Severance | Q2 2020 Global Restructure Program | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Expected cost	10,000		10,000
Maximum | Site Closures | Q2 2020 Global Restructure Program
Restructuring Cost and Reserve [Line Items]
Expected cost	8,000		8,000
Maximum | Site Closures | Q2 2020 Global Restructure Program | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Expected cost	4,000		4,000
Maximum | Site Closures | Q2 2020 Global Restructure Program | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Expected cost	$ 4,000		$ 4,000

Restructuring and Other Charg_4

Restructuring and Other Charges, Net - Restructuring Components (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2021USD ($)position	Jun. 30, 2020USD ($)
Q2 2020 Global Restructure Program
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ 3,830	$ 24,120	$ 5,654	$ 24,120
Q2 2020 Global Restructure Program | Corporate and other
Restructuring Cost and Reserve [Line Items]
Positions | position			390
Restructuring and other charges	1,711	9,330	$ 1,711	9,330
Q2 2020 Global Restructure Program | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Positions | position			170
Restructuring and other charges	507	7,609	$ 803	7,609
Q2 2020 Global Restructure Program | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Positions | position			280
Restructuring and other charges	1,612	$ 7,181	$ 3,140	$ 7,181
Reductions-in-Force
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges			4,216
Reductions-in-Force | Q2 2020 Global Restructure Program
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges			3,623
Reductions-in-Force | Q2 2020 Global Restructure Program | Minimum
Restructuring Cost and Reserve [Line Items]
Expected cost	27,000		27,000
Reductions-in-Force | Q2 2020 Global Restructure Program | Minimum | Corporate and other
Restructuring Cost and Reserve [Line Items]
Expected cost	9,700		9,700
Reductions-in-Force | Q2 2020 Global Restructure Program | Minimum | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Expected cost	9,300		9,300
Reductions-in-Force | Q2 2020 Global Restructure Program | Minimum | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Expected cost	8,000		8,000
Reductions-in-Force | Q2 2020 Global Restructure Program | Maximum
Restructuring Cost and Reserve [Line Items]
Expected cost	29,000		29,000
Reductions-in-Force | Q2 2020 Global Restructure Program | Maximum | Corporate and other
Restructuring Cost and Reserve [Line Items]
Expected cost	11,000		11,000
Reductions-in-Force | Q2 2020 Global Restructure Program | Maximum | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Expected cost	10,000		10,000
Reductions-in-Force | Q2 2020 Global Restructure Program | Maximum | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Expected cost	8,000		8,000
Site Closures | Q2 2020 Global Restructure Program
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	300
Site Closures | Q2 2020 Global Restructure Program | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges			300
Site Closures | Q2 2020 Global Restructure Program | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	1,000		2,000
Site Closures | Q2 2020 Global Restructure Program | Minimum
Restructuring Cost and Reserve [Line Items]
Expected cost	6,000		6,000
Site Closures | Q2 2020 Global Restructure Program | Minimum | Corporate and other
Restructuring Cost and Reserve [Line Items]
Expected cost	0		0
Site Closures | Q2 2020 Global Restructure Program | Minimum | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Expected cost	3,000		3,000
Site Closures | Q2 2020 Global Restructure Program | Minimum | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Expected cost	3,000		3,000
Site Closures | Q2 2020 Global Restructure Program | Maximum
Restructuring Cost and Reserve [Line Items]
Expected cost	8,000		8,000
Site Closures | Q2 2020 Global Restructure Program | Maximum | Corporate and other
Restructuring Cost and Reserve [Line Items]
Expected cost	0		0
Site Closures | Q2 2020 Global Restructure Program | Maximum | Performance Sensing
Restructuring Cost and Reserve [Line Items]
Expected cost	4,000		4,000
Site Closures | Q2 2020 Global Restructure Program | Maximum | Sensing Solutions
Restructuring Cost and Reserve [Line Items]
Expected cost	$ 4,000		$ 4,000

Restructuring and Other Charg_5

Restructuring and Other Charges, Net - Schedule of Restructuring and Other Charges, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Loss Contingencies [Line Items]
Restructuring and other charges, net	$ 5,029	$ 38,218	$ 9,611	$ 42,716
Wasica Finance Gmbh et al v. Schrader International Inc.
Loss Contingencies [Line Items]
Payments for legal settlements		12,100		12,100
Q2 2020 Global Restructure Program
Loss Contingencies [Line Items]
Q2 2020 Global Restructure Program charges	3,830	24,120	5,654	24,120
Other
Loss Contingencies [Line Items]
Severance costs, net	407	0	593	3,897
Facility and other exit costs	625	0	1,291	0
Other	$ 167	$ 14,098	$ 2,073	$ 14,699

Restructuring and Other Charg_6

Restructuring and Other Charges, Net - Schedule of Changes to Restructuring Liability (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Q2 2020 Global Restructure Program
Restructuring Reserve [Roll Forward]
Charges, net of reversals	$ (3,830)	$ (24,120)	$ (5,654)	$ (24,120)
Reductions-in-Force
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance			14,879
Charges, net of reversals			(4,216)
Payments			(7,819)
Foreign currency remeasurement			(71)
Restructuring Reserve, Ending Balance	11,205		11,205
Reductions-in-Force | Q2 2020 Global Restructure Program
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance			10,842
Charges, net of reversals			(3,623)
Payments			(4,931)
Foreign currency remeasurement			(103)
Restructuring Reserve, Ending Balance	9,431		9,431
Reductions-in-Force | Other
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance			4,037
Charges, net of reversals			(593)
Payments			(2,888)
Foreign currency remeasurement			32
Restructuring Reserve, Ending Balance	$ 1,774		$ 1,774

Other, Net (Details)

Other, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Other Income and Expenses [Abstract]
Currency remeasurement gain/(loss) on net monetary assets	$ 1,988	$ (1,097)	$ 511	$ 456
(Loss)/gain on foreign currency forward contracts	(1,419)	417	(2,377)	(3,364)
Gain/(loss) on commodity forward contracts	1,186	5,427	33	(148)
Loss on debt refinancing	0	0	(30,066)	0
Net periodic benefit cost, excluding service cost	(2,268)	(2,516)	(4,678)	(6,897)
Other	1,525	(655)	(1,808)	(752)
Other, net	$ 1,012	$ 1,576	$ (38,385)	$ (10,705)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Provision for/(benefit from) income taxes	$ 7,638	$ 1,441		$ 27,919	$ (75)
Deferred income tax benefit			$ 7,500

Net Income_(Loss) per Share - S

Net Income/(Loss) per Share - Schedule of Weighted Average Number of Shares (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Basic weighted-average ordinary shares outstanding (in shares)	158,208	157,186	157,986	157,392
Dilutive effect of stock options (in shares)	670	0	689	0
Dilutive effect of unvested restricted securities (in shares)	466	0	612	0
Diluted weighted-average ordinary shares outstanding (in shares)	159,344	157,186	159,287	157,392
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive effect of stock options (in shares)		66		200
Restricted securities
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive effect of stock options (in shares)		353		403

Net Income_(Loss) per Share -_2

Net Income/(Loss) per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Anti-dilutive shares excluded
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	8	2,959	7	2,172
Contingently issuable shares excluded
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,089	1,251	1,020	923

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Finished goods	$ 161,378	$ 170,488
Work-in-process	98,194	87,006
Raw materials	244,069	193,511
Inventories	$ 503,641	$ 451,005

Pension and Other Post-Retire_3

Pension and Other Post-Retirement Benefits - Schedule of components of net periodic benefit cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	$ 1,327	$ 942	$ 2,307	$ 1,713
Interest cost	542	638	1,087	1,257
Expected return on plan assets	(405)	(465)	(809)	(1,072)
Amortization of net loss	863	668	1,723	1,209
Amortization of prior service (credit)/cost	(146)	(194)	(302)	(388)
Loss on settlement	1,414	1,869	2,979	5,891
Net periodic benefit cost/(credit)	3,595	3,458	6,985	8,610
U.S. Plans | Defined Benefit
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	0	0	0	0
Interest cost	120	206	240	473
Expected return on plan assets	(226)	(293)	(452)	(726)
Amortization of net loss	401	300	802	595
Amortization of prior service (credit)/cost	0	0	0	0
Loss on settlement	1,414	310	2,979	4,332
Net periodic benefit cost/(credit)	1,709	523	3,569	4,674
U.S. Plans | Retiree Healthcare
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	2	3	4	5
Interest cost	21	36	42	73
Expected return on plan assets	0	0	0	0
Amortization of net loss	0	9	0	19
Amortization of prior service (credit)/cost	(159)	(197)	(318)	(393)
Loss on settlement	0	0	0	0
Net periodic benefit cost/(credit)	(136)	(149)	(272)	(296)
Non-U.S. Plans | Defined Benefit
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	1,325	939	2,303	1,708
Interest cost	401	396	805	711
Expected return on plan assets	(179)	(172)	(357)	(346)
Amortization of net loss	462	359	921	595
Amortization of prior service (credit)/cost	13	3	16	5
Loss on settlement	0	1,559	0	1,559
Net periodic benefit cost/(credit)	$ 2,022	$ 3,084	$ 3,688	$ 4,232

Debt - Schedule of Long-term De

Debt - Schedule of Long-term Debt, Finance Lease, and Other Financing Obligations (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Less: discount, net of premium	$ (6,097)	$ (9,605)
Less: deferred financing costs	(29,224)	(28,114)
Less: current portion	(4,629)	(754,630)
Long-term debt, net	4,213,830	3,213,747
Finance lease and other financing obligations	29,872	30,506
Less: current portion	(2,652)	(2,575)
Finance lease and other financing obligations, less current portion	$ 27,220	27,931
4.875% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.875%
5.625% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	5.625%
5.0% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	5.00%
6.25% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	6.25%
4.375% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.375%
3.75% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3.75%
4.0% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.00%
Secured Debt | Term Loan
Debt Instrument [Line Items]
Gross long-term debt	$ 453,780	456,096
Senior Notes | 4.875% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.875%
Gross long-term debt	$ 500,000	500,000
Senior Notes | 5.625% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	5.625%
Gross long-term debt	$ 400,000	400,000
Senior Notes | 5.0% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	5.00%
Gross long-term debt	$ 700,000	700,000
Senior Notes | 6.25% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	6.25%
Gross long-term debt	$ 0	750,000
Senior Notes | 4.375% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.375%
Gross long-term debt	$ 450,000	450,000
Senior Notes | 3.75% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3.75%
Gross long-term debt	$ 750,000	750,000
Senior Notes | 4.0% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.00%
Gross long-term debt	$ 1,000,000	$ 0

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	Apr. 08, 2021	Mar. 29, 2021	Mar. 05, 2021	Mar. 05, 2021	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Feb. 03, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Loss on debt financing					$ 0	$ 0	$ 30,066,000	$ 0
Accrued interest					$ 46,100,000		$ 46,100,000			$ 53,600,000
6.25% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					6.25%		6.25%
4.0% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					4.00%		4.00%
4.875% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					4.875%		4.875%
5.625% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					5.625%		5.625%
5.0% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					5.00%		5.00%
4.375% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					4.375%		4.375%
3.75% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					3.75%		3.75%
3.75% Senior Notes | Debt Instrument, Redemption Term, Scenario Two
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		101.00%
3.75% Senior Notes | Debt Instrument, Redemption Term, Scenario Three
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		100.00%
3.75% Senior Notes | Debt Instrument, Redemption Period, Prior to April 15, 2024 | Debt Instrument, Redemption Term, Scenario Three
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		104.00%
3.75% Senior Notes | Debt Instrument, Redemption Period, Prior to April 15, 2024 | Maximum | Debt Instrument, Redemption Term, Scenario One
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage of principal amount redeemed		40.00%
3.75% Senior Notes | Debt Instrument, Redemption Period, Beginning April 15, 2024
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		102.00%
3.75% Senior Notes | Debt Instrument, Redemption Period, Beginning April 15, 2024 | Minimum | Debt Instrument, Redemption Term, Scenario One
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage of principal amount redeemed		60.00%
3.75% Senior Notes | Debt Instrument, Redemption Period, Beginning April 15, 2025
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		101.00%
3.75% Senior Notes | Debt Instrument, Redemption Period, Beginning April 15, 2026 and thereafter
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		100.00%
Senior Notes | 6.25% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					6.25%		6.25%
Debt redemption, aggregate principal amount									$ 750,000,000
Debt instrument, redemption price, percentage			103.125%
Debt redemption, accrued interest				$ 2,600,000
Loss on debt financing							$ 30,100,000
Debt redemption, premium paid							$ 23,400,000
Senior Notes | 4.0% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					4.00%		4.00%
Debt instrument, face amount		$ 750,000,000
Debt redemption, premium paid							$ 1,700,000
Deferred financing costs					$ 9,600,000		$ 9,600,000
Senior Notes | Senior Notes 4.0% Due 2029, Additional Notes
Debt Instrument [Line Items]
Debt instrument, face amount	$ 250,000,000
Debt instrument, issued price as percentage of face value	100.75%
Senior Notes | 4.875% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					4.875%		4.875%
Senior Notes | 5.625% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					5.625%		5.625%
Senior Notes | 5.0% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					5.00%		5.00%
Senior Notes | 4.375% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					4.375%		4.375%
Senior Notes | 3.75% Senior Notes
Debt Instrument [Line Items]
Stated interest rate					3.75%		3.75%
Revolving Credit Facility | Line of Credit
Debt Instrument [Line Items]
Amount available under revolving credit facility					$ 416,100,000		$ 416,100,000
Line of credit facility, maximum borrowing capacity					420,000,000		420,000,000
Letters of credit outstanding, amount					3,900,000		3,900,000
Letter of Credit | Line of Credit
Debt Instrument [Line Items]
Long-term line of credit					$ 0		$ 0

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details)	Jun. 30, 2021USD ($)
Equity [Abstract]
Stock repurchase program, authorized amount	$ 500,000,000
Remaining amount under share repurchase program	$ 302,300,000

Shareholders' Equity - AOCI Rol

Shareholders' Equity - AOCI Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	$ 2,790,643	$ 2,537,797	$ 2,705,486	$ 2,573,755
Other comprehensive income	3,070	(3,495)	19,060	(19,487)
Ending Balance	2,913,448	2,493,405	2,913,448	2,493,405
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance			(6,733)
Other comprehensive income before reclassifications, net of tax			11,871
Reclassifications from accumulated other comprehensive loss, net of tax			3,805
Other comprehensive income			15,676
Ending Balance	8,943		8,943
Defined Benefit and Retiree Healthcare Plans
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance			(42,802)
Other comprehensive income before reclassifications, net of tax			0
Reclassifications from accumulated other comprehensive loss, net of tax			3,384
Other comprehensive income			3,384
Ending Balance	(39,418)		(39,418)
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	(33,545)	(36,476)	(49,535)	(20,484)
Other comprehensive income before reclassifications, net of tax			11,871
Reclassifications from accumulated other comprehensive loss, net of tax			7,189
Other comprehensive income			19,060
Ending Balance	$ (30,475)	$ (39,971)	$ (30,475)	$ (39,971)

Shareholders' Equity - AOCI Rec

Shareholders' Equity - AOCI Reclassifications (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net revenue	$ 992,660	$ 576,505	$ 1,935,188	$ 1,350,774
Cost of revenue	658,285	412,443	1,293,634	978,849
Income/(loss) before taxes	120,554	(41,100)	194,568	(34,185)
Other, net	1,012	1,576	(38,385)	(10,705)
Provision for/(benefit from) income taxes	(7,638)	(1,441)	(27,919)	75
Net income/(loss)	112,916	(42,541)	166,649	(34,110)
(Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss | Derivative instruments designated and qualifying as cash flow hedges:
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income/(loss) before taxes	1,409	(6,199)	5,073	(14,590)
Provision for/(benefit from) income taxes	(352)	1,550	(1,268)	3,648
Net income/(loss)	1,057	(4,649)	3,805	(10,942)
(Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss | Derivative instruments designated and qualifying as cash flow hedges: | Foreign currency forward contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net revenue	3,433	(6,392)	7,840	(13,015)
Cost of revenue	(2,024)	193	(2,767)	(1,575)
(Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss | Defined benefit and retiree healthcare plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other, net	2,131	2,343	4,400	6,712
Provision for/(benefit from) income taxes	(459)	(671)	(1,016)	(1,698)
Net income/(loss)	$ 1,672	$ 1,672	$ 3,384	$ 5,014

Fair Value Measures - Schedule

Fair Value Measures - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Level 2 - Recurring - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Assets
Foreign currency forward contracts	$ 17,789	$ 16,163
Commodity forward contracts	5,479	8,902
Total	23,268	25,065
Liabilities
Foreign currency forward contracts	7,667	24,660
Commodity forward contracts	2,016	310
Total	$ 9,683	$ 24,970

Fair Value Measures - Financial

Fair Value Measures - Financial Instruments Not Recorded at Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
4.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	4.875%
5.625% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	5.625%
5.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	5.00%
6.25% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	6.25%
4.375% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	4.375%
3.75% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	3.75%
4.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	4.00%
Level 2 | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 453,780	$ 454,955
Level 2 | 4.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	533,750	538,750
Level 2 | 5.625% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	444,000	448,000
Level 2 | 5.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	777,000	777,000
Level 2 | 6.25% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	0	778,125
Level 2 | 4.375% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	473,625	487,125
Level 2 | 3.75% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	740,625	776,250
Level 2 | 4.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	1,010,000	0
Level 2 | Carrying Value | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	453,780	456,096
Level 2 | Carrying Value | 4.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	500,000	500,000
Level 2 | Carrying Value | 5.625% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	400,000	400,000
Level 2 | Carrying Value | 5.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	700,000	700,000
Level 2 | Carrying Value | 6.25% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	0	750,000
Level 2 | Carrying Value | 4.375% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	450,000	450,000
Level 2 | Carrying Value | 3.75% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	750,000	750,000
Level 2 | Carrying Value | 4.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 1,000,000	$ 0

Fair Value Measures - Equity In

Fair Value Measures - Equity Instruments without Readily Determinable Fair Values (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Equity investment	$ 65,000	$ 65,000
Quanergy
Schedule of Equity Method Investments [Line Items]
Equity investment	50,000	50,000
Other
Schedule of Equity Method Investments [Line Items]
Equity investment	$ 15,000	$ 15,000

Derivative Instruments and He_3

Derivative Instruments and Hedging Activities - Narrative (Details)	Jun. 30, 2021USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Foreign currency cash flow gain to be reclassified during next 12 months	$ 9,200,000
Termination value of outstanding derivatives in a liability position	9,700,000
Collateral already posted, aggregate fair value	$ 0

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities - Schedule of Derivative Instruments (Details) - 3 months ended Jun. 30, 2021 € in Millions, ₩ in Millions, ¥ in Millions, ¥ in Millions, £ in Millions, RM in Millions, $ in Millions	EUR (€)oztlb$ / $$ / RM£ / $$ / ¥$ / ¥€ / $$ / ₩	CNY (¥)$ / $$ / RM£ / $$ / ¥$ / ¥€ / $$ / ₩	JPY (¥)$ / $$ / RM£ / $$ / ¥$ / ¥€ / $$ / ₩	KRW (₩)$ / $$ / RM£ / $$ / ¥$ / ¥€ / $$ / ₩	MYR (RM)$ / $$ / RM£ / $$ / ¥$ / ¥€ / $$ / ₩	MXN ($)$ / $$ / RM£ / $$ / ¥$ / ¥€ / $$ / ₩	GBP (£)$ / $$ / RM£ / $$ / ¥$ / ¥€ / $$ / ₩
Foreign currency forward contracts | Not designated | Euro ("EUR") to USD
Hedges of Foreign Currency Risk
Notional | €	€ 14
Weighted-Average Strike Rate | € / $	1.19	1.19	1.19	1.19	1.19	1.19	1.19
Foreign currency forward contracts | Not designated | USD to Chinese Renminbi ("CNY")
Hedges of Foreign Currency Risk
Notional | ¥		¥ 696
Weighted-Average Strike Rate | $ / ¥	6.51	6.51	6.51	6.51	6.51	6.51	6.51
Foreign currency forward contracts | Not designated | USD to Japanese Yen ("JPY")
Hedges of Foreign Currency Risk
Notional | ¥			¥ 450
Weighted-Average Strike Rate | $ / ¥	110.82	110.82	110.82	110.82	110.82	110.82	110.82
Foreign currency forward contracts | Not designated | USD to Malaysian Ringgit ("MYR")
Hedges of Foreign Currency Risk
Notional | RM					RM 26
Weighted-Average Strike Rate | $ / RM	4.14	4.14	4.14	4.14	4.14	4.14	4.14
Foreign currency forward contracts | Not designated | USD to Mexican Peso ("MXN")
Hedges of Foreign Currency Risk
Notional | $						$ 423
Weighted-Average Strike Rate | $ / $	19.92	19.92	19.92	19.92	19.92	19.92	19.92
Foreign currency forward contracts | Not designated | British Pound Sterling ("GBP") to USD
Hedges of Foreign Currency Risk
Notional | £							£ 5.6
Weighted-Average Strike Rate | £ / $	1.39	1.39	1.39	1.39	1.39	1.39	1.39
Foreign currency forward contracts | Cash flow hedge | Euro ("EUR") to USD
Hedges of Foreign Currency Risk
Notional | €	€ 370.4
Weighted-Average Strike Rate | € / $	1.19	1.19	1.19	1.19	1.19	1.19	1.19
Foreign currency forward contracts | Cash flow hedge | USD to Chinese Renminbi ("CNY")
Hedges of Foreign Currency Risk
Notional | ¥		¥ 520.8
Weighted-Average Strike Rate | $ / ¥	6.66	6.66	6.66	6.66	6.66	6.66	6.66
Foreign currency forward contracts | Cash flow hedge | USD to Korean Won ("KRW")
Hedges of Foreign Currency Risk
Notional | ₩				₩ 20,066.7
Weighted-Average Strike Rate | $ / ₩	1,143.12	1,143.12	1,143.12	1,143.12	1,143.12	1,143.12	1,143.12
Foreign currency forward contracts | Cash flow hedge | USD to Mexican Peso ("MXN")
Hedges of Foreign Currency Risk
Notional | $						$ 3,215
Weighted-Average Strike Rate | $ / $	22.41	22.41	22.41	22.41	22.41	22.41	22.41
Foreign currency forward contracts | Cash flow hedge | British Pound Sterling ("GBP") to USD
Hedges of Foreign Currency Risk
Notional | £							£ 51.3
Weighted-Average Strike Rate | £ / $	1.33	1.33	1.33	1.33	1.33	1.33	1.33
Silver | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	24.51	24.51	24.51	24.51	24.51	24.51	24.51
Hedges of Commodity Risk
Notional	929,084
Gold | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	1,819.10	1,819.10	1,819.10	1,819.10	1,819.10	1,819.10	1,819.10
Hedges of Commodity Risk
Notional	8,943
Nickel | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	7.44	7.44	7.44	7.44	7.44	7.44	7.44
Hedges of Commodity Risk
Notional | lb	202,117
Aluminum | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	0.97	0.97	0.97	0.97	0.97	0.97	0.97
Hedges of Commodity Risk
Notional | lb	2,870,170
Copper | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	3.76	3.76	3.76	3.76	3.76	3.76	3.76
Hedges of Commodity Risk
Notional | lb	2,842,272
Platinum | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	1,045.46	1,045.46	1,045.46	1,045.46	1,045.46	1,045.46	1,045.46
Hedges of Commodity Risk
Notional	9,540
Palladium | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	2,457.28	2,457.28	2,457.28	2,457.28	2,457.28	2,457.28	2,457.28
Hedges of Commodity Risk
Notional	1,256

Derivative Instruments and He_5

Derivative Instruments and Hedging Activities - Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Cash flow hedge
Derivatives, Fair Value [Line Items]
Asset Derivatives	$ 17,735	$ 16,009
Liability Derivatives	7,212	24,016
Not designated
Derivatives, Fair Value [Line Items]
Asset Derivatives	5,533	9,056
Liability Derivatives	2,471	954
Foreign currency forward contracts | Cash flow hedge | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	14,875	11,281
Foreign currency forward contracts | Cash flow hedge | Other assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	2,860	4,728
Foreign currency forward contracts | Cash flow hedge | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	6,928	18,834
Foreign currency forward contracts | Cash flow hedge | Other long-term liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	284	5,182
Foreign currency forward contracts | Not designated | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	54	154
Foreign currency forward contracts | Not designated | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	455	644
Commodity forward contracts | Not designated | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	5,041	7,598
Commodity forward contracts | Not designated | Other assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	438	1,304
Commodity forward contracts | Not designated | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	1,216	149
Commodity forward contracts | Not designated | Other long-term liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	$ 800	$ 161

Derivative Instruments and He_6

Derivative Instruments and Hedging Activities - Income Statement Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Foreign currency forward contracts | Net revenue | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income/(Loss)	$ (6,353)	$ (5,954)	$ 12,446	$ 6,590
Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss)	(3,433)	6,392	(7,840)	13,015
Foreign currency forward contracts | Cost of revenue | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income/(Loss)	6,808	5,267	3,383	(24,363)
Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income/(Loss)	2,024	(193)	2,767	1,575
Foreign currency forward contracts | Other, net | Not designated
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Net Income/(Loss)	(1,419)	417	(2,377)	(3,364)
Commodity forward contracts | Other, net | Not designated
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Net Income/(Loss)	$ 1,186	$ 5,427	$ 33	$ (148)

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - USD ($) $ in Thousands	Feb. 11, 2021	Jun. 30, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Goodwill		$ 3,308,939	$ 3,111,349
Xirgo
Business Acquisition [Line Items]
Aggregate purchase price	$ 408,700
Goodwill		$ 184,260

Acquisitions - Assets Acquired

Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Goodwill	$ 3,308,939	$ 3,111,349
Xirgo
Business Acquisition [Line Items]
Net working capital, excluding cash	11,536
Property, plant and equipment	1,427
Goodwill	184,260
Other intangible assets	249,612
Other assets	508
Deferred income tax liabilities	(45,506)
Other long-term liabilities	(292)
Fair value of net assets acquired, excluding cash and cash equivalents	401,545
Cash and cash equivalents	7,117
Fair value of net assets acquired	$ 408,662

Acquisitions - Schedule of Fini

Acquisitions - Schedule of Finite-Lived Intangible Assets Acquired and Weighted Average Useful Lives (Details) - Xirgo $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value	$ 249,612
Weighted-Average Lives (years)	14 years
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value	$ 198,540
Weighted-Average Lives (years)	15 years
Completed technologies
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value	$ 44,130
Weighted-Average Lives (years)	10 years
Tradenames
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value	$ 6,930
Weighted-Average Lives (years)	11 years
Other
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value	$ 12
Weighted-Average Lives (years)	1 year

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2021USD ($)segment	Jun. 30, 2020USD ($)
Segment Reporting [Abstract]
Number of reporting segments | segment			2
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	$ 992,660	$ 576,505	$ 1,935,188	$ 1,350,774
Operating income/(loss)	164,755	(1,868)	322,209	56,731
Amortization of intangible assets	(34,857)	(32,743)	(66,921)	(65,835)
Interest expense, net	(45,213)	(40,808)	(89,256)	(80,211)
Other, net	1,012	1,576	(38,385)	(10,705)
Income/(loss) before taxes	120,554	(41,100)	$ 194,568	(34,185)
Performance Sensing
Reconciliation from Segment Totals to Consolidated [Abstract]
Number of operating segments | segment			2
Net revenue	741,852	385,207	$ 1,456,364	953,896
Sensing Solutions
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	250,808	191,298	478,824	396,878
Operating segments
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	992,660	576,505	1,935,188	1,350,774
Operating income/(loss)	278,613	116,543	541,351	308,118
Operating segments | Performance Sensing
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	741,852	385,207	1,456,364	953,896
Operating income/(loss)	202,064	60,756	397,908	195,802
Operating segments | Sensing Solutions
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	250,808	191,298	478,824	396,878
Operating income/(loss)	76,549	55,787	143,443	112,316
Corporate and other
Reconciliation from Segment Totals to Consolidated [Abstract]
Operating income/(loss)	(73,972)	(47,450)	(142,610)	(142,836)
Segment reconciling items
Reconciliation from Segment Totals to Consolidated [Abstract]
Amortization of intangible assets	(34,857)	(32,743)	(66,921)	(65,835)
Restructuring and other charges, net	$ (5,029)	$ (38,218)	$ (9,611)	$ (42,716)